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ABSTRACT 
White adipose tissue (WAT) lipolysis is initiated via direct sympathetic nervous 
system (SNS) innervation and activation. SNS control to WAT is vital to maintaining 
homeostasis in response to metabolic challenges such as food deprivation and cold 
exposure. Using transneuronal viral tract tracers, we have identified sensory nerves 
from WAT that project to brainstem and forebrain areas critical to metabolic function. 
In addition, these sensory circuits from fat communicate with SNS outflow neurons that 
project back to fat—forming neural feedback loops throughout the CNS—providing 
neuroanatomical evidence for sensory WAT-SNS crosstalk. It is unclear, however, what 
role these WAT-specific sensory nerves serve to inform the CNS of acute and dynamic 
metabolic challenges to which it can then respond. Here we tested mechanisms of 
activation of WAT sensory nerves and present a working model to deepen our 
understanding of why these neural circuits act as conduits for acute metabolic feedback 
signals from WAT. Neurochemical, neuroanatomical, and neurophysiological evidence 
supports the presence of: 1) WAT lipolytic sensors from a neural population known to be 
capable of controlling SNS outflow; and 2) functional neural links among fat depots 
mediated via the peripheral and central nervous systems. 
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1 INTRODUCTION  
The U.S. census reports that 67% of Americans are overweight or obese, creating 
a healthcare-related economic burden that exceeds $140 billion annually ("Centers for 
Disease Control and Prevention ", 2009). Complications of obesity include 
hypertension, cardiovascular disease, type II diabetes, stroke and some cancers 
("Centers for Disease Control and Prevention ", 2009) and contribute to up to 26.8% of 
U.S. deaths annually (Masters et al., 2013). Clearly, uncovering effective obesity reversal 
strategies will improve the health of millions of people, reduce obesity-related deaths, 
and decrease healthcare costs associated with increased body fat. A relatively unstudied 
facet of obesity reversal is the investigation of neural circuits that emanate from fat 
tissue and are networked to brain regions capable of controlling energy balance via the 
sympathetic nervous system (SNS). With the exception of the largely unsuccessful 
efforts to reverse so-called ‘leptin resistance’ to the adipose-derived satiety hormone 
(Myers et al., 2012), few studies have examined the functional connectedness of fat 
tissue to the brain as a means to counteract obesity. Therefore, the purpose of this 
dissertation is to review our current knowledge of adipose afferent nerve sensitivities 
and functions, demonstrate new and physiologically relevant functions of these nerves, 
and consolidate this new information into a synthetic working model in order to 
generate testable hypothesis regarding the emerging role of adipose afferent nerves in 
energy balance.  
1.1 Global obesity and its reversal 
People who are overweight (BMI = 25 through 30) or obese (BMI > 30) are at 
risk for deleterious comorbidities, many of which are associated with the ectopic and 
overabundant storage of white adipose tissue (WAT). As of 2014, this includes 
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approximately 1.9 billion individuals around the globe: 39% of all adults worldwide; and 
this number has more than doubled since 1980 (W.H.O., 2014). Thankfully, body mass 
reduction by diet and exercise can attenuate or even resolve symptoms of obesity-
induced hypertension, type 2 diabetes (Lewis, 2013), respiratory distress (Dattani, 
Swerner, Stradling, & Manuel, 2016), infertility (Dag & Dilbaz, 2015), and sleep apnea 
(Quintas-Neves, Preto, & Drummond, 2016). This shift in healthiness by fat reduction 
may be due to many factors associated with better diet and exercise (Dankel, Loenneke, 
& Loprinzi, 2016); however, surgical removal of white fat also rapidly alleviates 
comorbidity symptoms such as insulin insensitivity and hyperlipidemia (Crahay & Nizet, 
2016). This suggests that the presence of fat itself produces negative consequences. 
Clearly, WAT mass reduction by better diet and exercise is healthful and therefore a 
variety of obesity reversal strategies have been employed. In order to discover the many 
possible ways permanent obesity reversal may be accomplished, we must know how fat 
depot size is regulated and functionally how to control this regulation.  
1.2 Introduction to adipose tissue 
Adipocytes, or fat cells, vary in size and structure and perform a variety of 
specialized functions throughout the body. Two primary types of adipocytes each 
comprise large depots throughout the body known as WAT and brown adipose tissue 
(BAT) (Fig. 1), whose similarities and differences will be discussed in detail here. 
However, other types of fat are not trivial and exist in bone, joints, ectopically within 
other organs, and are reviewed elsewhere (Grundy, 2016; Mace, Bhatti, & Anand, 2016; 
Scheller, Cawthorn, Burr, Horowitz, & MacDougald, 2016). In general, WAT adipocytes 
store excess energy in the form of triglycerides (TAG) and BAT adipocytes expends 
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energy by burning lipid during nonshivering thermogenesis. This broad dichotomy often 
brings one to assume WAT is bad and BAT is good; however, this conclusion is 
somewhat flawed. White fat mobilization is engaged when glucose stores have been 
depleted, thus fuel utilization after the exhaustion of or beyond the rate provided by 
WAT reflect a state of extreme depletion. This results in wasting and associated 
consequences (Kyle & Pichard, 2006)—with obesity being a possible evolutionary 
survival strategy to prevent wasting (Prentice, 2005). Lipodystrophy—a disorder 
characterized by the inability to store fat at appropriate sites—is associated with a 
spectrum of disorders including insatiable appetite, insulin resistance, and cardio 
myopathies (Seip & Trygstad, 1996). WAT, conversely, becomes extremely unhealthy 
after unregulated accumulation that inevitably leads to its sometimes fatal 
comorbidities (Lewis, 2013). BAT, on the other hand, is primarily considered beneficial 
and performs thermogenic and glucoregulatory functions (van Marken, 2012). Its 
energy consumption often correlates with fat loss and the general reversal of obesity 
(Cannon & Nedergaard, 2004b; Carey & Kingwell, 2013; Nedergaard, Bengtsson, & 
Cannon, 2011). Although WAT and BAT are both types of adipose tissues, their 
metabolic functions, regulatory mechanisms, and even cell lineages are remarkably 
distinct (Carey & Kingwell, 2013; Wu et al., 2012).   
1.2.1 Brown adipose tissue (BAT) physiology 
Largely studied in rodents but also shown to be active in humans (Nedergaard, 
Bengtsson, & Cannon, 2007), BAT is a thermogenic tissue that expends energy and is 
thus an important contributor to the energy balance equation (Carey & Kingwell, 2013). 
Human BAT is more active in winter months (Au-Yong, Thorn, Ganatra, Perkins, & 
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Symonds, 2009) and is acutely activated by cold (Sacks et al., 2013). Its activity also 
contributes to better glucose regulation and reduced risk for type 2 diabetes (Cannon & 
Nedergaard, 2004a). In rodents, BAT is localized primarily in the interscapular region 
(Tchkonia et al., 2013) but also in pericardial, subclavical, and supraspinal regions; 
whereas, human primary BAT depots are pericardial,  subclavical, supraspinal and are 
absent from the interscapular region in adulthood (Tchkonia et al., 2013) (Fig. 1a, b). 
Indeed, animals with higher BAT activity tend to be thinner, more glucose tolerant, and 
illustrate a healthier inflammatory profile than their counterparts with low BAT activity 
(Krief, Bazin, Dupuy, & Lavau, 1989; Stanford et al., 2013; Vijgen et al., 2012). In 
addition, many clinical investments target BAT activation as a strategy to treat human 
obesity. Therefore, recent research initiatives have focused on BAT growth, BAT activity, 
BAT transplantation in BAT deficient animals, and the browning of WAT to resemble 
Figure 1. Adipose distribution (Tchkonia et al., 2013) and cellular ultrastructure of WAT 
and BAT (Cinti, 1999). 
a-b) Figure from (Tchkonia et al., 2013). a) Rodent and b) human distribution of WAT and BAT. c-d) 
Figure from (Cinti, 1999). Electron microscopy of c) epididymal white and d) interscapular brown 
adipocytes: n, nucleus; m, mitochondria; L, lipid droplet; CAP, capillary.  
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BAT all to test how this tissue contributes to better metabolic health (Carey & Kingwell, 
2013).  
BAT adipocytes generate heat using their numerous mitochondria and (Fig. 1d) 
specialized thermogenic gene expression profile. When glucose is insufficient, then 
either BAT intracellular TAG stores, gluconeogenesis, and circulating lipids released by 
WAT fuel are capable of fueling BAT thermogenesis (Labbé et al., 2015). In brief, fatty 
acids and glucose are usually used to generate ATP; however, BAT cells produce 
uncoupling-protein 1 (UCP1) which creates a mitochondrial protein leak that dissipates 
heat (Fedorenko, Lishko, & Kirichok, 2012). This heat production by BAT is increased 
during cold exposure, becomes more efficient and robust when animals are chronically 
exposed to cold, and is triggered by SNS activity (Festuccia, Blanchard, Richard, & 
Deshaies, 2010). Astonishingly, BAT itself contributes to approximately one half of all 
energy expended by cold-acclimated small rodents despite comprising less than one 
percent of total body mass (Cannon & Nedergaard, 2004a). In obese rodents and 
humans, BAT is less active and has a lower capacity for cold-induced activity than lean 
counterparts (Lidell & Enerback, 2010). This demonstrates that reduced BAT function is 
either caused by or contributes to the development of obesity. Therapeutic intervention 
by enhancing BAT function may therefore prevent or reverse obesity development by 
improving metabolic health in individuals at risk.  
Results from studies using transplantation of BAT into BAT-deficient rodent 
models tests the potential for non-native BAT to rescue rodent models of obesity and 
glucose-intolerance. Autologous BAT transplant into the visceral cavity restores glucose 
sensitivity in streptozotocin-induced diabetic mice, suggesting that BAT glucose 
utilization is sufficiently high to rescue pancreatic islet cell destruction (Gunawardana & 
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Piston, 2012). To illustrate the potentially versatile benefits of enhanced BAT function, 
BAT implantation also rescues menstrual irregularity in rodent models of polycystic 
ovarian syndrome (Yuan et al., 2016).  These data together illustrate that a greater 
amount of BAT, and theoretically enhanced activity of native BAT, may improve 
dysregulated functions across several organ systems. Sympathomimetics that increase 
BAT activity in rodents have little to no effect in humans (Cypess et al., 2012). However, 
recent advances in BAT transplantation methodology (Tharp et al., 2015) established 
that human BAT transplantation is approaching a clinical possibility.  
Inspired by the advantages of targeting BAT to achieve better metabolic health, 
many researchers are using this strategy to enhance the BAT-like functional 
characteristics of WAT: known colloquially as ‘browning’ or ‘beiging.’ Indeed, some 
WAT adipocytes are capable of transitioning from a lipid storage cell across an adipocyte 
continuum to instead burn lipid by the induction of a somewhat brown or ‘beige’ state, a 
transition brought on almost exclusively by chronic stimulation by the sympathetic 
nervous system (SNS) (Cannon & Nedergaard, 2004a). Not all WAT adipocytes are 
capable of browning, and importantly, beige adipocytes are not identical to classical 
brown adipocytes most notably due to their divergence from different cell lineages (Wu 
et al., 2012). These distinctions, however, do not prevent browned WAT depots from 
generating measureable heat during cold exposure and thereby contribute to enhanced 
energy expenditure when stimulated (Wu, Cohen, & Spiegelman, 2013). Thus, WAT 
browning is poised to mediate obesity reversal by both generating heat to expend 
energy, and by reducing the amount of classical WAT mass (Ishibashi & Seale, 2010).  
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1.2.2 White adipose tissue (WAT) physiology  
Classical WAT adipocytes store large vacuoles of lipid as TAG and have relatively 
few mitochondria (Figure 1a). In addition to its role as a secretory organ (Scherer, 
2006), a primary function of this tissue is to store excess lipid during periods of energy 
surplus and release lipid as fuel during periods of energy deficit. During energy surplus, 
WAT accumulates lipid by hypertrophy (i.e. growing in size) and by hyperplasia (i.e. 
becoming more numerous in cell number) to accommodate more TAG (Bourgeois, 
Alexiu, & Lemonnier, 1983). In rodents, WAT depots are stored in five stereotypically 
identified regions (Fig. 1c) with three being subcutaneous (e.g. dorsal, inguinal), others 
abdominal (e.g. perigonadal, retroperitoneal) and one visceral fat pad (e.g. mesenteric) 
defined by its venous draining directly into hepatic portal circulation (Tchkonia et al., 
2013). Humans, however, store subcutaneous fat more homogeneously across the body 
and, in the case of visceral obesity, have a large visceral omental fat depot under the 
greater curvature of the stomach (Tchkonia et al., 2013). In rodents, individual control 
of WAT depot size is accomplished by direct SNS outflow capable of delivering NE to 
distinct depots in differential degrees (Brito, Brito, Baro, Song, & Bartness, 2007; Brito, 
Brito, & Bartness, 2008).   
Indeed, stimulated WAT lipolysis and BAT thermogenesis are triggered by SNS 
stimulation. This notion is supported by broad expression of α1, 2 and β1, 2, 3 adrenergic 
receptors (β-ARs) on adipocytes (Lafontan & Berlan, 1993), NE content within the 
tissue, and ex vivo responses of cultured adipocytes to NE. WAT lipolysis is stimulated 
when norepinephrine released by axon terminals of post ganglionic SNS neurons binds 
to β-adrenoreceptors (β-ARs)—present on adipocytes (Lafontan et al., 1997)—initiating 
a lipolytic cascade that is dependent on the phosphorylation of hormone sensitive lipase 
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(HSL) leading to the preferential release of long-chain free-fatty acids (FFAs) and 
glycerol from TAG stores (Bartness & Song, 2007a; Belfrage, Fredrikson, Nilsson, & 
Stralfors, 1981). WAT lipid droplets contain an array of saturated and unsaturated 
species of fatty acids in the form of TAG, spanning from characteristically short to long 
carbon chain species (Raclot, Mioskowski, Bach, & Groscolas, 1995). Although all FFAs 
are released during WAT lipolysis, polyunsaturated fatty acids with longer carbon 
chains are mobilized to a higher degree (Raclot & Groscolas, 1993). Direct efferent 
innervation of the tissue, instead of circulating NE, is thought to stimulate WAT lipolysis 
and BAT thermogenesis because of the preserved SNS control of these functions after 
adrenalectomy (Edens, Moshirfar, Potter, Fried, & Castonguay, 1999; Holt, Wheal, & 
York, 1988). 
1.3 Communication from adipose tissue to the brain 
Adipose communication by neurohumoral factors was first described directly 
with the discovery of leptin (Zhang et al., 1994); however more recent studies also define 
an additional robust and interconnected sensory neural component of this tissue 
(Bartness, Liu, Shrestha, & Ryu, 2014a; Giordano, Morroni, Santone, Marchesi, & Cinti, 
1996). Adipose sensory nerve activity is an emerging contributor to blood pressure 
regulation and likely other metabolic processes via broadly triggering SNS activation 
(Niijima, 1998), this is despite any demonstration that WAT or BAT can generate signals 
that communicate to the sensory nerves innervating the tissue. Because of the potential 
for sensory innervation of WAT and BAT to affect SNS outflow, uncovering mechanisms 
by which WAT and BAT activate their afferents may reveal key strategies for how 
adipocyte function is integrated with many organ systems.  
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To assess candidate activators of adipose afferents and targets of endocrine 
communication, we begin with listing the probable types of messages fat may be sending 
regarding its state and functions. WAT and BAT activity can be generally refined to 
several distinct roles such that identifying these basic functions makes clear several 
likely outgoing messages from fat to adipose afferents. 1) Lipogenesis is a crucial 
ongoing process to animal survival preparing for unforeseen physiological challenges 
(e.g. cold exposure, periods of famine); 2) Lipolysis is the breakdown and release of lipid 
as fuel, which is rapidly triggered when glucose is insufficient and energy demand is 
high; 3) BAT and ‘browned’ WAT thermogenesis also is a context-dependent rapidly 
triggered process that is vital to rodent survival in a cold environment. These three 
general functions of WAT and BAT occur during specific physiological states wherein 
lipolysis and thermogenesis are high during energy challenge; lipogenesis occurs 
primarily during energy surplus. Consequently, lipolysis and thermogenesis are vital to 
survival during scarcity of food and warmth whereas lipogenesis occurs largely during 
abundance of food and states of rest (Ng, 1990). It is unclear, however, if or how the 
state of these adipose processes are signaled to other organs; but by the nature of their 
design, endocrine signaling likely favors tonic messages while local paracrine fat to 
neural signaling most likely favors acutely relevant adipocyte functions.   
1.3.1 Circulating factors as adipose communication 
Signaling polyproteins secreted by adipocytes, or adipokines, are a diverse pool of 
molecules and contribute to a wide variety of physiological processes including but not 
limited to energy expenditure, insulin sensitivity (Dyck, Heigenhauser, & Bruce, 2006; 
Mullen et al., 2009), cardiovascular function (Salazar et al., 2016), immune function 
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(Odegaard & Chawla, 2013), hunger, and even reproduction (Reverchon, Ram, Bertoldo, 
& Dupont, 2014). Among the over hundreds of adipokines identified (Halberg, 
Wernstedt-Asterholm, & Scherer, 2008; Scherer, 2006), leptin and adiponectin are 
perhaps the most highly studied. Leptin is secreted by fat based on the amount of 
accumulated lipid evidenced by serum levels proportional to the amount of stored WAT. 
It is colloquially referred to as the ‘adiposity hormone.’ Adiponectin, which is present in 
serum inversely proportional to fat mass, precedes insulin insensitivity by its 
diminished levels in blood (Lee & Shao, 2014). As with other adipokines, leptin exerts its 
effects at many targets (e.g. brain, peripheral nervous system, liver, bone, heart, 
gastrointestinal tract) and is thought to inform the body of the general amount of 
adipose tissue. Mechanisms of leptin resistance, a term that describes the insufficiency 
for exogenous leptin to inhibit appetite and reduce body mass in the case of diet-
induced obesity, are sought after by many and believed to be driven by leptin receptor 
sensitization, downregulation, and/or diminished permeability of leptin into the brains 
of obese animals. However, leptin resistance as a phenomenon may be misguided due to 
the apparent hyperphagia induced by leptin absence compared with little to no effect on 
feeding after exogenous administration and/or exaggerated levels during an obese state 
(Allison & Myers, 2014). A more reasonable explanation is the impaired functioning of 
downstream signaling in metabolic neuronal populations because of enhanced 
suppressor of cytokine 3 or an otherwise enhanced inflammatory profile (Myers, 2015). 
Clearly, leptin as well as adipokines are examples of adipocytes signaling to other tissues 
and can become dysregulated during disease conditions (e.g. obesity and diabetes).  
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1.3.2 Peripheral innervation of adipose tissue 
In addition to endocrine signaling by adipokines, it is clear that local paracrine 
communication between adipocytes and neurons within fat depots occurs on a rapid 
scale. Efferent, or motor,  innervation of fat was clearly defined with the first observance 
of direct efferent connectivity in 1898 by Dogiel (Dogiel, 1898), and many have 
demonstrated functional integration of SNS into fat tissue (for review see (Bartness et 
al., 2014a). Afferent, sensory innervation of fat, however, was not anatomically 
identified until 1987 by Fishman and Dark (Fishman & Dark, 1987) and has been 
studied to a relatively underwhelming degree.  
1.3.2.1 Sensory nerve phenotype 
First identified using the true blue neurotracer directly into WAT (Fishman & 
Dark, 1987), WAT and BAT afferents share a common neurochemical profile with 
nociceptive free nerve endings throughout the body. Immunohistochemical 
identification of WAT afferents in the tissue reveals expression of sensory nerve markers 
calcitonin-gene related peptide (CGRP) and substance P indicating the presence—or the 
absence—of sensory innervation (Giordano et al., 1996). Electron microscopy of WAT 
afferents using these markers reveals a mix of both myelinated and unmyelinated fibers 
that are congregated predominately around vasculature of the innervated tissue (De, 
Ricquier, & Cinti, 1998).  
These afferents, like other afferents innervating skin, muscle, and liver, are 
pseudo-unipolar neurons , with a single axon bifurcating where one arm extends to the 
sensory organ and the other arm projecting into the spinal cord to synapse with dorsal 
horn neurons at the level of spinal entry (Tandrup, 1995). Tracing studies suggest that 
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WAT and BAT afferents are spinal neurons, in that their cell bodies are located together 
among a group of cell bodies outside the spinal cord known collectively as the dorsal 
root ganglion (DRG) (Fishman & Dark, 1987). To understand the functional roles of 
WAT sensory innervation, DRGs are extracted post-mortem to characterize neuro-
traced adipose afferents using immunohistochemistry (Murphy et al., 2013) and in situ 
hybridization (Oliveira et al., 2003). DRG analysis of WAT afferent nerves is often 
preferred to tissue level analysis due to cell body access and possible occlusion of 
afferent fibers by adipocytes that make distinguishing WAT from afferent nerve receptor 
protein expression difficult; further, immediate early genes (e.g. c-Fos, pERK) are 
common proxies for neuronal activity and are only present in cell bodies (Hoffman, 
Smith, & Verbalis, 1993). Using this method together with immunohistochemistry for 
the long form leptin receptors (ObRb), we have demonstrated that WAT afferents are 
activated by injection of leptin into WAT (Murphy et al., 2013). Functional evidence 
described in depth below also suggests that WAT afferents express adenosine receptors 
and capsaicin-sensitive transient potential vallinoid receptors (TrpVRs) (Shi et al., 
2012).  
1.3.2.2 Motor nerve phenotype 
As with other SNS fibers that send output to organs (e.g. liver, pancreas, heart), 
WAT efferent/motor nerves are neurochemically homogenous in that most are 
identified by catecholaminergic markers (e.g. dopamine β-hydroxylase, tyrosine 
hydroxylase) and neuropeptide Y (NPY). Transneuronal viral neurotracing of WAT 
reveals broad neuronal populations in brain and spinal regions discussed in detail 
below; however, neurotracing to WAT pads whose catecholaminergic innervation has 
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been depleted by a SNS-specific neurotoxin—6-hydroxy-dopamine—results in no 
apparent innervation across the peripheral and central neuraxis (Giordano et al., 2006). 
The finding that parasympathetic nervous system (PSNS) innervation of fat has been 
described as well (Kreier et al., 2002). This is controversial, however, because classical 
markers of PSNS are not present in adipose tissue (Ballantyne, 1968; Giordano et al., 
2006). Thus, evidence that adipose motor nerves are entirely catecholaminergic suggest 
that PSNS innervation is trivial at best (Giordano et al., 2005; Giordano et al., 2007; 
Lundberg, Terenius, Hokfelt, & Goldstein, 1983).  
Control of SNS WAT and BAT efferent nerves drives lipolysis and thermogenesis 
of WAT and BAT, respectively (Bartness et al., 2014a); therefore, mechanisms of WAT 
and BAT efferent control are those which coincide with energy expenditure to a large 
degree. Although many attempts have been made to pharmacologically mimic SNS 
output to promote fat loss in humans (Omran, 2016), most therapies include 
concomitantly increased cardiovascular risk (Siebenhofer et al., 2016). To this end, 
specific SNS activation of adipose efferents is a primary goal to achieve safe obesity 
reversal in humans.  
1.3.3 Central innervation of adipose tissue 
We have established efferent and afferent neural circuits of BAT and WAT by 
using transneuronal viral tract tracers (Bamshad, Song, & Bartness, 1999; Bartness, 
Song, Shi, Bowers, & Foster, 2005; Bowers et al., 2004; Ryu, Garretson, Liu, Vaughan, & 
Bartness, 2015b; Song, Schwartz, & Bartness, 2009). These methods rely on infection of 
neural tissue after parenchymal viral injection into single or multiple tissue depots. 
Bartha K Pseudorabies virus strains (PRV) that express green (PRV152) or red (PRV614) 
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fluorescent proteins specifically infect neurons from the ends of their circuit to the 
beginning, infecting neuronal pathways in a retrograde fashion with viral uptake 
occurring at the nerve terminals (Strack & Loewy, 1990). These two viruses have been 
used to trace differences in efferent innervation between multiple fat pads (Nguyen, 
Randall, Banfield, & Bartness, 2014) and elucidated shared and divergent neural 
pathways to individual depots. Herpes simplex virus strain 129 (HSV129) infects 
neuronal pathways in an anterograde fashion (Barnett, Evans, Sun, Perlman, & Cassell, 
1995), traveling from the beginning of neural circuits to the end with viral uptake 
occurring at dendritic processes. Viral infection of PRVs and HSV129 occurs when viral 
attachment molecules bind to neuronal glycoproteins. These are amplified by the 
infected cells, and then transmitted to connected neurons (Curanovic & Enquist, 2009; 
Ekstrand, Enquist, & Pomeranz, 2008). Although PRVs and H129 seem to infect all first 
order neurons despite their role as sensory or motor neurons in the tissue (Rinaman & 
Schwartz, 2004), viral transmission to the next neuron in the circuit occurs via distinct 
differences in their axonal transport and synaptic transmission. Therefore, these viruses 
have been key tools to illustrate the central efferent and afferent neural circuits 
connected to adipose tissue.  
Using both PRV152 and HSV129 in the same animal, we have illustrated 
individual neurons that both receive sensory input from and project SNS outflow to 
WAT (Bartness & Song, 2007b) and to BAT (Ryu et al., 2015b). These double labeled 
neurons throughout the neuraxis are presumably each capable of relaying sensory input 
from fat into SNS outflow to fat. We find that most double-labeled neurons reside in the 
mid and hindbrain (Bartness et al., 2014a). Based on the accumulating evidence that 
WAT afferent activation increases in SNS activity (Li et al., 2013; Niijima, 1998), these 
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relay neurons likely propagate a feed-forward WAT-brain-SNS circuit meaning afferent 
activation leads to efferent activation. Indeed, adipose-initiated SNS reflexes that do not 
require cortical function are supported by the neuroanatomical localization of midbrain 
and brainstem WAT-BAT circuits sufficient to drive BAT thermogenesis in the absence 
of neural connectivity with structures rostral to the midbrain. For example, cooling of 
the skin increases BAT thermogenesis in decorticated but not decerebrated rats (Osaka, 
2004), a reflex action believed to originate by BAT afferent activation.  
1.4 Sensation and functions of adipose afferent nerves inferred by 
denervation experiments 
WAT and BAT afferents have been demonstrated to contribute to distinct 
biological functions such as SNS feedback regulation to multiple tissues (Niijima, 1998, 
1999), SNS-induced hypertension (Xiong, Chen, & Zhu, 2014), regulation of fat 
deposition throughout the body (Shi & Bartness, 2005), and food intake regulation 
(Yamada et al., 2006). These functions have been elucidated by two primary approaches 
to date. First, loss of function experiments using surgical denervation or excitotoxic 
chemical denervation by high dose capsaicin (Jancso et al., 1984) or resinerfertoxin 
(Acs, Biro, Acs, Modarres, & Blumberg, 1997) infused into adipose tissue of anesthetized 
rodents. The second approach to test WAT and BAT afferent function is accomplished 
by recording extracellular neurophysiological activity in anesthetized animals beginning 
with Niijima’s discovery that leptin activates WAT afferents (Niijima, 1999) and more 
recently with understanding mechanisms of the adipose afferent reflex (AAR) (Shi et al., 
2012; Xiong et al., 2012; Xiong et al., 2014). This section will discuss technical details of 
these approaches as well as their advantages and disadvantages to interrogate adipose 
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afferent neurophysiological stimulators and physiological processes engaged by 
increased adipose afferent activity.  
1.4.1 Technical approaches to denervation 
Surgical or chemical destruction of peripheral nerves innervating tissues are 
exclusion experiments designed to test the role of neural connectivity by categorically 
comparing intact with denervated animals to infer chronic neural function. These 
experiments, although quite useful for establishing necessity of WAT and BAT afferent 
connectivity, have two critical flaws in that both 1) lack specificity and 2) rely on a 
surgical recovery period of weeks during which some degree of reinnervation of the 
tissue and/or other physiological compensation will likely occur. Both surgical and 
chemical methods consistently reduce or abolish sensory nerve markers (e.g. substance 
P, CGRP) within fat tissue compared with control animals suggesting that despite these 
shortcomings each technique is adequate for testing the necessity of WAT and BAT 
afferent functions. Tissues that are specifically targeted by these methods are the 
interscapular BAT, perigonadal (GWAT), or the subcutaneous inguinal WAT (IWAT). 
Whole animal deafferentation by capsaicin, although non-specific to adipose afferents, 
is relevant to this discussion and will be referenced in regard to adipose functions 
controlled by afferents. 
Surgical denervation of WAT and BAT is completed by physically removing a 
portion of all nerves innervating each tissue, which prevents adipose tissue from 
emitting sensory neural signals (Vaughan, Zarebidaki, Ehlen, & Bartness, 2014). During 
this procedure, a small section of each nerve is removed using two precise cuts—
instead—of a single cut to reduce the likelihood of nerve regrowth by a neural system 
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unknown in its regenerative capacity. This type of denervation is performed while the 
animal is anesthetized, typically takes 2-3 min per fat pad, has only been completed in 
rodents. To successfully accomplish this task and completely destroy all innervation of 
the target fat pad, the surgeon must non-specifically destroy nerves innervating 
overlaying skin—subcutaneous fat—or nearby organs possibly innervated by shared 
nerve bundles. The nonspecific denervation of other organs more likely occurs with 
GWAT surgical denervation compared with IWAT and IBAT due to their relative 
proximities to other organs (e.g. gonads) (Cinti, 1999). By definition, surgical 
denervation mutes bidirectional communication of both sensory signals arising from fat 
and, importantly, motor signals communicated by the brain to fat. Thus, despite surgical 
denervation being the most complete method to abolish adipose sensory signals, its 
equal removal of SNS outflow to fat often excludes it as an independent tool to 
investigate the role of sensory specific innervation. Consequently, surgical denervation 
is often accompanied with more chemically specific approaches when adipose afferent 
function is considered.  
Chemical denervation by high doses of capsaicin (Jancso et al., 1984) or 
resinerfertoxin (Acs et al., 1997) infusion into fat involves controlled surgical 
microinjections throughout the target tissue (Vaughan et al., 2014) to cause 
excitotoxicity of sensory neurons specifically. During this procedure, sub-microliter 
volumes of fluid are infused into as many as 20 loci across the entire fat pad to produce 
the most robust decreases in sensory innervation—as measured by CGRP protein 
content in homogenized tissue 3-6 weeks after recovery (Vaughan & Bartness, 2012). 
For each locus of injection, the microsyringe needle is held in place for 1 min to 
minimize efflux of fluid outside the pad and reduce the spread to non-specific tissues; 
18 
thus this surgery takes up to 20 min per fat pad and therefore requires a considerably 
longer duration of anesthesia than with surgical denervation. Due to the duration of 
time spent injecting the fat pad and the surgical recovery period thereafter, acute 
conclusions from adipose afferent destruction studies are often avoided.  
The most profound flaw of chemical denervation is that it does not completely 
abolish sensory innervation within the tissue. Typically, successful chemical denervation 
results in a reduction in total CGRP protein of as little as ~40-50% less than vehicle-
injected control tissues (Vaughan & Bartness, 2012). This is either due to the excitotoxin 
not reaching all adipose afferents in the fat pad or that both capsaicin and 
resinerfertoxin target transient receptor potential cation channel subfamily V member 1 
(TrpV1) receptors which may be present on some but not all CGRP-positive sensory 
neurons (Koltzenburg, 2004). Although this sensory nerve destruction is clearly not as 
complete as surgical destruction of afferents, its specificity to sensory not motor neurons 
is paramount. The physiological effects it produces marks this as the most useful tool to 
test metabolic processes that require functionally intact adipose afferents.  
1.4.2 Adipose afferent sensation and function inferred by denervation 
experiments 
These loss of function studies describe the variety of physiological functions that 
required adipose afferent innervation. Surgical removal of fat from one specific depot 
causes increased lipid accumulation in other fat depots, we demonstrated that this 
compensation exists in Siberian hamsters (Mauer & Bartness, 1994). It also can be 
mimicked by WAT afferent chemical destruction (Shi, Song, Giordano, Cinti, & 
Bartness, 2005), suggesting that WAT afferents provide ‘inventory’ data to the CNS 
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which then compensates for the loss of fat by adding more elsewhere (Mauer, Harris, & 
Bartness, 2001). In addition, chemical denervation of IWAT or EWAT afferents 
contributes to a regulation of fat cell proliferation (Shi et al., 2005).  
General connectivity between WAT afferents and BAT has been investigated 
following chemical deafferentation of rats by systemic capsaicin (Cui & Himms-Hagen, 
1992a; Cui, Zaror-Behrens, & Himms-Hagen, 1990; Melnyk & Himms-Hagen, 1994). 
After systemic capsaicin treatment, rats have diminished BAT thermogenic capacity 
(Giordano et al., 1998) and atrophy of the IBAT tissue depot (Cui & Himms-Hagen, 
1992b; Cui et al., 1990). These studies suggest that afferent nerve throughout the body 
functionality contributes to healthy BAT function and provokes curiosity into the 
specific location of the afferents that control of BAT.  
Only one study demonstrates that adipose afferents exert effects on the 
innervated tissue by the local release of neuropeptides. This signaling mechanism is well 
defined in other innervated tissues [e.g. muscle (Dvorakova, Kruzliak, & Rabkin, 2014)] 
but otherwise novel to adipocyte afferent innervation. CGRP released by BAT afferent 
nerves reduces sensitivity of BAT adipocytes to NE thus attenuating SNS-induced 
thermogenesis (Osaka et al., 1998). Neuropeptide release by WAT afferents may 
perform similar functions although this has yet to be investigated. As a potent 
vasodilator (Tippins, 1986), CGRP’s release by adipose afferents may increase adipose 
blood flow to enhance the reception or extravasation of lipid by the adipose organs. 
1.4.3 Technical approach to neurophysiological recordings 
Extracellular nerve recordings of adipose innervation are a targeted surgical 
approach to test for the control of afferent or efferent function of these nerves in an 
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anesthetized rodent. To date, adipose afferent recordings have only been accomplished 
in rats and Siberian hamsters, the former due to their larger relative size and the latter 
because of the detailed illustrations of adipose innervation revealed by tract tracing 
studies (Bamshad et al., 1999; Bartness et al., 2005; Bowers et al., 2004; Ryu et al., 
2015b; Song et al., 2009).  Critical to this technique is effective surgical isolation of 
anatomically connected nerves innervating the tissue and electrical isolation of the 
desired signal (i.e. afferent or efferent). When examining adipose afferent function, this 
technique involves infusing the target fat depot with a candidate chemical to test for the 
sufficiency to activate sensory fibers monitored by the recording electrode. Each of these 
strategies, however, must be performed under urethane or ketamine/xylazine 
anesthesia wherein the rodents’ temperature regulation, metabolic rate, respiration, and 
blood pressure are all unlike that of an awake animal. Because of these limitations, 
experiments using this method explicitly exclude behavioral measures and perhaps are 
solely capable to identify acute perturbations that mechanistically control adipose 
afferents and efferent activity. 
1.4.4 Adipose afferent sensation and function demonstrated by 
neurophysiological recording experiments 
Niijima was the first to demonstrate experimental activation of WAT afferents by 
measuring increased afferent spiking after leptin infusion into epididymal WAT 
(GWAT) (Niijima, 1998). Adipose activation induced by leptin is repeated in a series of 
studies (Niijima, 1998, 1999; Shi et al., 2012), it occurs within minutes after the onset of 
infusion, and is also apparent in neurons arising from inguinal WAT (Murphy et al., 
2013; Shi et al., 2012; Xiong et al., 2012; Xiong et al., 2014). In addition, Niijima was the 
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first to demonstrate that neurophysiological recordings of adipose nerves was possible, 
and served as the principal exploration into a new method by which WAT afferent 
sensitivity can be established. Niijima further discovered leptin-induced GWAT afferent 
activation reflexively increases in SNS outflow to GWAT and broadly dampens vagal 
nerve PSNS outflow (Niijima, 1999), also serving as the first identification that efferent 
outflow could by triggered by WAT afferent activation. 
WAT afferent-induced SNS outflow, later termed the ‘adipose afferent reflex’ 
(AAR), has been extended by Zhu and colleagues into an apparent sufficiency of IWAT 
afferent activity to trigger renal SNS outflow thereby increasing blood pressure. This 
positive reflex is initiated by IWAT activation which can be induced by leptin but also by 
bradykinin, adenosine, and the indiscriminate activator of sensory nerves, capsaicin. 
The WAT afferent activators not included by Niijima (e.g. bradykinin, adenosine) 
further extend the role of WAT afferents to monitor the release of a variety of ligands 
from adipocytes and implicate WAT afferents in organ systems. Overall, Zhu and 
colleagues argue that WAT afferents sensitive to leptin are involved in SNS increases 
causing hypertension. This positive feedback may be responsible for the high 
comorbidity between obesity and hypertension in humans. Adenosine receptors A1 and 
A2 on adipocytes regulate fat lipolysis as well (Johansson, Lindgren, Yang, Herling, & 
Fredholm, 2008); thus, sensation of adenosine by WAT afferents vaguely suggests 
lipolysis is an event that stimulates their activity. Bradykinin, however, is primarily 
released by the kidneys in response to increased blood pressure and therefore may serve 
as a message to WAT afferents regarding the status of circulation. Thus, this serves as a 
conduit that is important to adipose tissue for released lipolytic products to be 
circulated throughout the body as fuel. Overall, WAT afferent activation causes 
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increases in SNS outflow to multiple targets and these data highlight this neural circuit 
as mediator of SNS function overall. 
Despite the broad and seemingly redundant distribution of adipose afferent and 
efferent neural circuitry (Bartness & Song, 2007c; Song et al., 2009), the paraventricular 
nucleus of the hypothalamus (PVH) is a required brain region through which WAT 
afferent-induced hypertension occurs. Excitotoxic lesion of the PVH disrupts the AAR 
by attenuating increased renal SNS activity (Cui et al., 2013). Several lines of evidence 
have been proposed for the mechanism by which the PVH converts adipose afferent 
stimulation to SNS outflow. Indeed, blockade of PVH melanocortin 3 and 4 receptors 
produces similar AAR inhibition as PVH lesion, as also is the case for GABAa receptor 
antagonism (Ding et al., 2015a) and depletion of PVH supraoxide anions by the 
scavenger tempol (Ding et al., 2013). All of these explorations of the PVH involvement 
use capsaicin infusions into IWAT or GWAT as an AAR trigger which increases PVH 
field potentials; however, it is unclear if PVH disruption by any of these means prevents 
excited adipose afferents from causing SNS increases, or if central disruption of this 
pathway reduces excitability of adipose afferents by capsaicin. This shortcoming 
demonstrates fundamental questions that still exist in adipose afferent physiology 
because of the difficulty to capture the synchrony of organ systems using techniques 
currently available.  
The apparent increased SNS outflow has been of key interest among labs 
studying adipose afferent physiology; however, only we have produced a physiological 
challenge for the animal and measured subsequent adipose afferent responses (Song et 
al., 2009). Peripheral administration of 2-deoxy-glucose (2DG), a sympathomimetic 
that causes the β-adrenergic dependent breakdown of adipose tissue, also causes a 
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correlational increase in WAT afferent activity suggesting again that lipolysis, as also 
hinted by direct adenosine infusion into IWAT, causes WAT afferent stimulation. This 
suggests either that adipose afferents are stimulated by circulating products of lipolysis 
(e.g. FFAs and glycerol) or that they sense local secretions by their receptive fields 
within fat parenchyma. In order to dissociate these two possibilities, improved methods 
are needed to site specifically cause lipolysis and capture site specific afferent responses.  
1.5 Purpose of this dissertation 
After synthesis of the known characteristics of adipose afferents and their 
downstream functions, many inferences suggest activation by and interconnectedness of 
these fibers with other organ systems. Adipose afferents potentially control body fat 
deposition, general SNS outflow, and do so by their collective patterns of nerve activity 
that somehow drive coordinated organ level responses. Of the evidence provided, the 
research themes by others are focused on SNS-outflow produced by general adipose 
afferent activation; however, it is largely unclear under what physiological settings these 
nerves are activated. Indeed, correlational exploration of glucoprivation-induced 
afferent activation is the only study that demonstrates adipose afferents respond to 
adipocyte-derived signals based on a physiological reaction to enhanced SNS drive 
(Song et al., 2009). Instead, others have injected exogenous substances into WAT or 
BAT as in vivo pharmacological experiments by testing the capability of their ligand of 
choice to affect the adipose afferents hidden within the depot. To this effect, injecting 
leptin into WAT—at a dose not justified to be physiologically relevant—to stimulate 
WAT afferents ignores the context in which adipocytes may release leptin to activate 
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these afferents in vivo. These tests essentially neglect the notion that specific functions 
of adipocytes cause afferent activation.  
Thus, we seek to understand what signals BAT and WAT adipocytes are capable 
of producing that control the activity of the afferent nerves residing within. We 
accomplish this by testing the hypothesis that SNS-outflow to BAT and WAT results in 
increased adipose afferent nerve activity; specifically, BAT afferents are thermosensors 
and WAT afferents are lipid sensors. We do so by using the β3-AR agonist CL 316,243 to 
target adipocytes within each depot then measuring subsequent reactions of BAT and 
WAT afferents. Measurements of afferent activity include neurophysiological recordings 
and neurotracing combined with c-Fos immunohistochemistry as a molecular marker of 
activation within connected DRGs. We continue this work by demonstrating 
neuroanatomical feedback loops comprised of BAT sensory and sympathetic nerves 
using transneuronal viral tract tracing. In addition, we establish a functional neural 
connection between WAT and BAT whereby WAT afferent activity drives BAT 
thermogenesis. Finally, we explore a novel chemogenetic strategy that permits 
measurement of the behavioral and metabolic consequences of adipose afferent activity 
in awake-behaving animals for the first time. Progress in developing this approach is 
discussed and additionally, we propose improvements based on this work for future 
studies.  
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2.1 Abstract 
Brown adipose tissue (BAT) is an important source of thermogenesis which is 
nearly exclusively dependent on its sympathetic nervous system (SNS) innervation. We 
previously demonstrated the SNS outflow from brain to BAT using the retrograde SNS-
specific transneuronal viral tract tracer, pseudorabies virus (PRV152) and demonstrated 
the sensory system (SS) inflow from BAT to brain using the anterograde SS-specific 
transneuronal viral tract tracer, H129 strain of herpes simplex virus-1. Several brain 
areas were part of both the SNS outflow to, and receive SS inflow from, interscapular 
BAT (IBAT) in these separate studies suggesting SNS-SS feedback loops. Therefore, we 
tested whether individual neurons participated in SNS-SS crosstalk by injecting both 
PRV152 and H129 into IBAT of Siberian hamsters. To define which dorsal root ganglia 
(DRG) are activated by BAT SNS stimulation, indicated by c-Fos immunoreactivity (ir), 
we pre-labeled IBAT DRG innervating neurons by injecting the retrograde tracer Fast 
Blue (FB) followed 1 wk later by intra-BAT injections of the specific β3-adrenoceptor 
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agonist CL316,243 in one pad and the vehicle in the contralateral pad. There were 
PRV152+H129 dually-infected neurons across the neuroaxis with highest densities in 
the raphe pallidus nucleus, nucleus of the solitary tract, periaqueductal gray, 
hypothalamic paraventricular nucleus and medial preoptic area, sites strongly 
implicated in the control of BAT thermogenesis. CL316,243 significantly increased IBAT 
temperature, afferent nerve activity and c-Fos-ir in C2-C4 DRG neurons ipsilateral to 
the CL316,243 injections versus the contralateral side. The neuroanatomical reality of 
the SNS-SS feedback loops suggests coordinated and/or multiple redundant control of 
BAT thermogenesis. 
2.2 Introduction 
Brown adipose tissue (BAT) is a critical for non-shivering thermogenesis in 
rodents and its physiological function is directly controlled by its sympathetic nervous 
system (SNS) innervation (Bartness, Vaughan, & Song, 2010; Richard & Picard, 2011). 
Rodent BAT has parasympathetic nervous system (PSNS) innervation of two minor BAT 
depots -- pericardial (Schafer, Eiden, & Weihe, 1998) and mediastinal (Giordano, 
Frontini, Castellucci, & Cinti, 2004), but not interscapular BAT (IBAT), the major 
rodent BAT depot (Giordano et al., 2004). Absence of BAT PSNS permits use of the viral 
transneuronal tracer pseudorabies virus (PRV; Bartha’s K strain) to define the origins of 
the SNS outflow innervating peripheral tissues [for review see: (Enquist, 2002; Song, 
Enquist, & Bartness, 2005)] including IBAT (Bamshad et al., 1999; Oldfield et al., 
2002). Increases in BAT SNS drive lead to release of norepinephrine (NE) from its SNS 
postganglionic nerve terminals thereby stimulating brown adipocyte β3-adrenoceptors 
[e.g., (Zhao, Unelius, Bengtsson, Cannon, & Nedergaard, 1994)] that ultimately activate 
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uncoupling protein-1 resulting in thermogenesis increases [for review see: (Cannon & 
Nedergaard, 2004b)]. This NE effect is mimicked by CL316,243, a highly selective β3-
adrenoceptor agonist both in vivo (Atgie, Faintrenie, Carpene, Bukowiecki, & Geloen, 
1998a; Himms-Hagen et al., 1994) and in vitro (Gabaldón, McDonald, & Horwitz, 
1998) 
BAT also has sensory system (SS) innervation. At the tissue level, IBAT has 
immunoreactivity (-ir) for two proven SS neuropeptides, substance P and calcitonin 
gene-related peptide (De et al., 1998; Norman, Mukherjee, Symons, Jung, & Lever, 
1988). Furthermore, with intra-IBAT injection of an anterograde transneuronal viral 
tract tracer, the H129 strain of herpes simplex virus 1 (HSV-1), we identified the central 
SS circuits from this tissue (Vaughan & Bartness, 2012). Many of the sites receiving SS 
input from IBAT (Vaughan & Bartness, 2012) also are part of the SNS outflow from the 
CNS to IBAT revealed by our PRV studies. Thus, this SNS-SS overlap between studies 
suggests the possibility of individual neurons that are part of the SNS outflow from 
brain to BAT that also receive SS input from the tissue – that is, potential SNS-SS 
feedback loops serving an anatomical basis for crosstalk between BAT SNS and SS 
innervations. Although the exact role of the BAT SS is unknown, the impairment of the 
thermogenic response of BAT to acute cold exposure due to sensory denervation 
accomplished via intra-IBAT injection of the sensory-specific neurotoxin capsaicin 
(Jansco, Kiraly, & Jansco-Gabor, 1980; Jansco, Kiraly, Joo, Such, & Nagy, 1985), 
strongly suggests BAT SS innervation is necessary for its optimal physiological 
functioning (Vaughan & Bartness, 2012). Therefore, we hypothesized that BAT SNS-SS 
feedback loops might exist and tested this as well as identifying which dorsal root 
ganglia (DRG) receive sensory input when IBAT is adrenergically-activated by: 1) 
29 
injecting both the SS-specific transneuronal tract tracer, H129, and the SNS-specific 
transneuronal tract tracer, PRV, intra-IBAT to test for dually-infected SNS-SS neurons, 
2) injecting CL316,243 intra-IBAT using c-Fos-ir to reveal activation (Hoffman et al., 
1993) of pseudounipolar neurons within the DRG pre-labeled with Fast Blue (FB) 
thereby identifying IBAT afferent neurons activated by IBAT adrenergic stimulation, 
and 3) measuring IBAT sensory nerve activity electrophysiologically after intra-IBAT 
CL316,243 injection. 
2.3 Methods and Materials 
In this study we used Siberian hamsters (Phodopus sungorus) because these 
animals provide an irreplaceable model over other rodent models to study a naturally-
occurring seasonal obesity as well as foraging and hoarding. Using this model, we 
established the origins of the efferent sympathetic (SNS) outflow from brain to WAT 
and BAT pads utilizing SNS-specific viral tract tracer PRV152. Moreover, we identified 
the central sensory centers innervating those fat pads using sensory-specific viral tract 
tracer H129 which altogether prepared neuroanatomical background for identification 
of SNS-SS circuits to characterize specific fat pads. 
2.3.1 Animals 
Adult male Siberian hamsters (Phodopus sungorus; ~3-4 mo old) from our 
breeding colony were single-housed in a long day photoperiod (16h:8h light:dark cycle; 
at 22 ± 2 ºC) with free access to water and regular chow for 1 wk before viral injections. 
All procedures were approved by the Georgia State University Institutional Animal Care 
and Use Committee and are in accordance with Public Health Service and United States 
Department of Agriculture guidelines. 
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2.3.2 Experiment 1: Viral injections 
All virus injections were performed according to Biosafety Level 2 standards. 
Hamsters (n=8) were anesthetized with isoflurane (2.0-3.0 % in oxygen; Baxter 
Healthcare, Deerfield, IL) and the left IBAT pad was exposed for a series of PRV152 (gift 
from Dr. Enquist, Princeton University) microinjections (7.5 x 107 pfu/ml) into five loci 
(150 nl/locus) evenly distributed across one IBAT pad. After 24 h, the same IBAT pad 
received five H129 (gift from Dr. Richard Dix, Georgia State University) microinjections 
(7.5 x 107 pfu/ml; 150 nl/locus). The syringe was held in place for 60 s to prevent efflux 
of virus after each injection. Finally, the incision was closed with sterile sutures and 
wound clips. Nitrofurozone powder (nfz Puffer; Hess & Clark, Lexington, KY) was 
applied locally to minimize the risk of bacterial infection. Note that previously we 
demonstrated that surgical isolation of the fat pad from the surrounding tissues before 
H129 injections results in a pattern of infection indistinguishable from that of pads 
injected in their natural in situ position suggesting the infections came directly from 
sensory nerves innervating the fat pad, but not the surrounding tissues [Song, C.K. and 
Bartness, T.J., unpublished observations]. As a control for possible viral diffusion, we 
also demonstrated that the same virus titer of PRV152 or of H129 and volume placed on 
the surface of the exposed IBAT pad resulted in no infection in the sympathetic ganglia 
or DRG, spinal cord, and brain as opposed to intra-IBAT pad viral infections (Ryu V and 
Bartness TJ, unpublished observations). In addition, we found both PRV152 and H129-
infected neurons in the intermediolateral cell column (IML) of the spinal cords (data not 
shown), respectively, suggesting specific IBAT-SNS ganglia and IBAT-SS DRG-spinal 
cord-brain routes of infection which are in concordance with our previous findings 
where PRV152 and H129 individually infected the classic SNS and SS spinal cord 
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neurons (Bamshad et al., 1999; Vaughan & Bartness, 2012). Finally, we have not noticed 
left-right pad differences in brain infections with injections of either PRV152 or H129. 
Note that pilot studies indicated no left-right IBAT differences (Vaughan, C.H. and 
Bartness, T. J.; and Song, C. K. and Bartness, T. J., unpublished observations) nor in our 
published work (Bamshad et al., 1999; Leitner & Bartness, 2009; Song et al., 2008; 
Vaughan & Bartness, 2012). 
2.3.3 Experiment 2: Fast Blue (FB) labeling and CL316,243 
administration 
One week before CL316,243 microinjections, Siberian hamsters (n=12) were 
deeply anesthetized with ketamine/xylazine (100 mg/kg, 10 mg/kg; i.p.) and a dorsal 2 
cm interscapular incision was made to expose IBAT. The retrograde tracer FB (1.0 %; 
EMS-CHEMIE GmbH, Gross-Umstadt, Germany) was injected with a microsyringe into 
five separate loci (1 µl/locus) of the left IBAT. After the last injection, the incision was 
closed with sterile wound clips and ketofen [5 mg/kg; s.c.; Fort Dodge Animal Health, 
Fort Dodge, IA] was administered for 3 d postinjection to minimize postoperative 
discomfort. 
For CL316,243 administration, two electronic transponders (Bio Medic Data 
Systems Inc., Seaford, were connected to BAT-10 Thermometer Physitemp (Physitemp 
Instruments Inc., Clifton, NJ). CL316,243 (0.2 ng/kg in 0.9 % saline), a highly selective 
β3-adrenoceptor agonist that stimulates facultative thermogenesis [e.g., (Himms-Hagen 
et al., 1994)], was injected intra-left IBAT at five loci (2 μl/locus for a total of 10 μl) 
while nearly simultaneous intra-right IBAT injections of CL) each with a built-in 
temperature sensor were gently implanted under each IBAT pad, the output of which 
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was read with a hand-held DAS-7007R scanner (Bio Medic Data Systems Inc.) for IBAT 
temperature (TIBAT) acquisition as we have used successfully previously (Brito et al., 
2007; Leitner & Bartness, 2009; Nautiyal et al., 2008; Song et al., 2008; Vaughan & 
Bartness, 2012; Vaughan, Shrestha, & Bartness, 2011). This system provides an 
opportunity to program the transponder with a unique identification code to distinguish 
between left and right IBAT pad temperatures. Core body temperature (Tb) in these 
anesthetized animals was measured using a rectal temperature sensor. The saline 
vehicle (2 μl/locus for a total of 10 μl) served as a within animal control. In preliminary 
studies, we determined that s.c. CL316,243 injections at 0.2 ng/kg failed to elevate TIBAT 
and therefore this dose was selected for IBAT microinjections [Ryu, V. and Bartness, 
T.J., unpublished observations]. Following each injection, the microsyringe needle was 
held in place for at least 1 min to minimize efflux. The incision was immediately closed 
with sterile wound clips and parallel temperature recordings from both IBAT pads as 
well as Tb were monitored every 5 min for 1 h post injection (observation time based on 
pilot studies showing little or, most often, no change in temperatures after that time 
[Ryu, V. and Bartness, T. J., unpublished observations). 
2.3.3.1 Histology 
Animals were terminated 6 d after the last PRV152 injections (5 d after the last 
H129 injections) based on progression of both viruses to the brain in pilot studies (Ryu, 
V. and Bartness, T. J, unpublished observations). Hamsters were overdosed with 
pentobarbital sodium (Sleep Away; 300 mg/kg) and transcardially perfused with 0.9 % 
heparinized saline followed by 4.0 % paraformaldehyde in 0.1 M phosphate buffered 
saline (PBS; pH 7.4). The brains were collected and post-fixed in the same fixative for 3-
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4 h at 4 °C, then transferred to a 30.0 % sucrose solution in 0.1 M PBS with 0.1 % 
sodium azide and stored at 4 °C until they were sectioned on a freezing stage sliding 
microtome at 30 μm. Sections were stored in 0.1 M PBS solution with 0.1 % sodium 
azide until processed for double immunofluorescence. 
For the CL316,243 experiment, the hamsters were euthanized with pentobarbital 
sodium (Sleep Away; 300 mg/kg) immediately after individual temperature recordings 
and transcardially perfused (see above). DRG associated with vertebral levels C1-T5 
were extracted bilaterally, the epineurium debrided from the ganglia, post-fixed in the 
same fixative for 15 min and transferred to an 18.0 % sucrose solution in 0.1 M PBS with 
0.1 % sodium azide at 4 °C overnight. DRG were sectioned longitudinally at 20 μm and 
directly mounted onto slides (Superfrost Plus; VWR International, West Chester, PA) in 
three series with every forth section on the same slide. This procedure yielded ~24 
sections with each slide containing eight sections. Therefore, multiplying the number 
per section by 24 will give an estimated total neuronal number per ganglion. 
For the double-label fluorescent immunohistochemistry, free-floating brain 
sections were rinsed in 0.1 M PBS (2 x 15 min) followed by a 30 min blocking in 10.0 % 
normal goat serum (NGS; Vector Laboratories, Burlingame, CA) and 0.4 % Triton X-100 
in 0.1 M PBS. Next, sections were incubated with a mixture of primary rabbit anti-HSV-
1 antibody (1:2000; DakoCytomation, Carpinteria, CA) and mouse anti-GFP antibody 
(1:700; Abcam, Cambridge, MA) for 18 h. Sections were then incubated in the mixture of 
the secondary goat anti-rabbit (1:700; Jackson Immunoresearch, West Grove, PA) and 
goat anti-mouse Alexa-488 (1:700; Jackson Immunoresearch) antibodies with 2.0 % 
NGS and 0.4 % Triton X-100 in 0.1 M PBS for 2 h at room temperature. For 
immunohistochemical controls, the primary antibody was either omitted or 
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preadsorbed with the immunizing peptide overnight at 4 °C resulting in no 
immunoreactive staining. Sections were mounted onto slides (Superfrost Plus) and 
coverslipped using ProLong Gold Antifade Reagent (Life Technologies, Grand Island, 
NY). 
After rehydration, DRG sections were processed for detection of H129 (anti-HSV-
1 antibody, 1:100 dilution; DakoCytomation) and PRV152 (anti-GFP antibody, 1:500 
dilution; Abcam) directly on the slides using the same immunohistochemical protocol as 
above. 
For DRG c-Fos immunostaining on the slides, sections were rinsed in 0.1 M PBS 
(2 x 15 min) followed by 1 h blocking in 5.0 % normal horse serum (NHS; Vector 
Laboratories) and 0.3 % Triton X-100 in 0.1 M PBS. Sections were then incubated in the 
primary rabbit anti-c-Fos (1:500; sc-52; Santa Cruz Biotech, Santa Cruz, CA) antibody 
with 10.0 % NHS and 0.3 % Triton X-100 in 0.1 M PBS overnight. Next, the sections 
were incubated in the secondary donkey anti-rabbit Cy3 (1:200; Jackson 
Immunoresearch) for 3 h, rinsed with 0.1 M PBS (3 x 15 min) and coverslipped with 
ProLong Gold Antifade Reagent (Life Technologies). All steps were performed at room 
temperature. 
2.3.4 Experiment 3: Electrophysiological recordings of IBAT afferent 
nerve activity 
Siberian hamsters (n=10) were anesthetized with ketamine/xylazine (100 mg/kg, 
10 mg/kg; i.p.), a 2 cm dorsal interscapular incision made, IBAT and connective tissue 
resected exposing nerves innervating right IBAT lobe. Single nerves were isolated with a 
petroleum jelly barrier, severed, then the decentralized nerve placed on silver (32-
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guage) hook electrodes to measure afferent activity. A petroleum jelly mineral oil 
mixture (1:1) was applied to the site completely enveloping the electrode/nerve 
connection, and then warm mineral oil was pooled into the recording area to insulate 
electrical noise, secure the nerve on the electrode, and reduce drying of tissue. A steady 
anesthetic plane was maintained with supplemental ketamine by examining toe pinch 
repeatedly on all four paws and testing the eye blink response throughout the recording. 
Three stainless steel needles connected with silastic tubing to microsyringes affixed to a 
microsyringe infusion pump were inserted into right IBAT along the lateral-coronal 
plane spaced 4-5 mm apart at a depth of 4 mm each. In a pilot experiment, we used this 
delivery system for intra-IBAT application of Evan’s blue dye as a visual surrogate for 
CL316,243 and found that the whole ventral IBAT pad turned blue showing excellent 
distribution of fluid across the pad by this method (Garretson, J. T. and Bartness, T. J., 
unpublished observations). Ten minutes of basal electrical activity was measured and 
served as baseline. At that point, 15 µl of CL316,243 (0.2 ng/kg) or the saline vehicle was 
infused at a rate of 3.0 µl/min and recording continued. 
Extracellular signals were amplified 10,000 times with a differential AC amplifier 
set to low pass filter 100 Hz and high pass filter 1000 Hz (Model 1700; A-M Systems, 
Sequim, WA). The analog signal was visualized using an oscilloscope (2530, BK 
Precision, Yorba Linda, CA) to optimize signal-to-noise ratio and concurrently identified 
via an audio analyzer (74-30-1; FHC, Bowdoin, ME). Data were digitized through 
Digidata 1440a data acquisition system (1440a; Molecular Devices, Sunnyvale, CA), 
recorded with accompanying Clampex 10.3 software at a 20,000 Hz sampling rate, then 
analyzed for number of spikes based on a voltage threshold two standard deviations 
above mean non-signal noise via the Clampfit 10.2 data analysis software package. All 
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identified waveforms were visually screened whereby any aberrant signals counted by 
the software were easily identified and removed from the analyses. 
2.3.4.1 Quantitative and statistical analysis 
Images were viewed and captured using 100x and 200x magnification with an 
Olympus DP73 imaging photomicroscope (Olympus, Tokyo, Japan) with appropriate 
filters for Cy3 and Alexa-488. The single-labeled PRV152 and H129, c-Fos and FB 
images were evaluated and overlaid with the aid of CellSens (Olympus) and the Adobe 
Photoshop CS5 (Adobe Systems, San Jose, CA) software. In every sixth brain section, we 
counted cells showing SNS PRV152+SS H129-ir, single cells with PRV152- or H129-ir as 
well as c-Fos-ir and FB labeling in every forth DRG section using the manual tag feature 
of the Adobe Photoshop CS5 software thus eliminating the likelihood of counting the 
same neurons more than once. Absolute neuronal numbers as well as their 
corresponding percentages in the brain and DRG were averaged across each examined 
region/nucleus/ganglion from all animals. A mouse brain atlas (Paxinos & Franklin, 
2007) was used to identify brain areas because no Siberian hamster brain atlas is 
available and because of the similarity in size and shape of most of the brain structures 
between Siberian hamsters and mice. For the preparation of the photomicrographs, we 
used Adobe Photoshop CS5 (Adobe Systems) only to adjust the brightness, contrast and 
sharpness, to remove artifactual obstacles (i.e., obscuring bubbles) and to make the 
composite plates. 
Temperature data were analyzed by one-way repeated measures analysis of 
variance (ANOVA) followed by Holm-Sidak’s or Bonferroni’s least significant difference 
(PLSD) post-hoc tests using NCSS (version 2007, Kaysville, UT). For 
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electrophysiological analysis, spike number across time was quantified by collapsing the 
spikes into 10 min bins from the onset of infusion up to 20 min post infusion. The 
percent change of mean nerve activity from baseline was compared using a 2 x 2 
analysis ANOVA (time x drug), and post hoc analysis of drug effects at individual time 
points using Student’s t-test with Bonferroni’s correction. Significance was set at 
P<0.05. For simplicity and clarity, exact test results and exact P values are not 
presented. 
2.4 Results 
Following viral infections, hamsters remained asymptomatic until Day 5 after 
PRV152 and Day 4 after H129 inoculation, whereupon many began to display some 
symptoms of infection including occasional slight loss of body weight and decreased 
mobility, but most often an ungroomed coat. All hamsters were euthanized the next day 
for histological analyses when such symptoms became apparent. Five out of 8 animals 
were equally infected by both PRV152 and H129 viral tracers throughout the neuroaxis 
from the hindbrain to the forebrain and therefore were included in the analyses. Three 
other animals exhibited over-infection of the CNS either by PRV152 and/or H129 
indicated by widespread ‘cloudy plaques’ around the over-infected neurons and were 
excluded from the analysis. We noticed both PRV152- and H129-labeled (-infected) 
neurons in the IML of the spinal cord (data not shown) with the latter SS innervation of 
the IML in accordance with studies showing SS presence in the IML of 
amphibians(Horn & Stofer, 1989), prenatal laboratory mice(Funakoshi et al., 2003), 
laboratory rats (Yamamoto, Senba, Matsunaga, & Tohyama, 1989) and Djungarian 
(Siberian) hamsters (Reuss, 1993). 
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2.4.1 Experiment 1: Viral infections in the brain 
The dual injections of the SNS nerve tract tracer PRV152 and the SS nerve tract 
tracer H129 unilaterally into the same (left) IBAT pad appeared bilaterally in the brain 
with slightly ipsilateral domination to the side of inoculation for both viruses.  
Both single- and double-labeled neurons were notably present in the hindbrain. 
Some of the hindbrain areas with the highest percentages of double-labeled PRV152- 
and H129-ir cells included the lateral paragigantocellular nucleus (LPGi; 13.0 ± 1.2 %; 
Table 1), raphe obscurus nucleus (ROb; 12.9 ± 1.4 %; Table 1 and Fig. 2A, B), medial 
parabrachial nucleus (MPB; 12.7 ± 1.1 %; Table 1), raphe pallidus nucleus (RPa; 12.6 ± 
1.1 %; Table 1 and Fig. 2A) and superior vestibular nucleus (SuVe; 12.1 ± 1.8 %; Table 1). 
The RPa and ROb also were among the regions with the highest absolute numbers of 
infected neurons (Table 1 and Figs. 2A, B; 3A). Overall, the percentage of double-labeled 
hindbrain neurons was ~10.0 % (Fig. 3B). 
The midbrain areas with the highest percentages of double-labeled PRV152- and 
H129-ir cells were the lateral periaqueductal gray (LPAG; 11.5 ± 2.1 %; Table 1) and 
ventrolateral periaqueductal gray (VLPAG; 10.3 ± 1.8 %; Table 1). Among the brain sites 
with a predominantly SNS efferent output to IBAT, as compared with a SS afferent input 
from the same IBAT pad, were the LPAG (F(1,9)=7.76; P<0.05; Table 1 and Fig. 1C, D), 
dorsolateral periaqueductal gray (DLPAG; F(1,9)=42.91; P<0.05; Table 1 and Fig. 2C) and 
dorsal raphe nucleus (DR; F(1,9)=5.35; P<0.05; Table 1 and Fig. 2C). As in the hindbrain, 
the overall percentage of midbrain double-labeled neurons was ~10.0 % (Fig. 3B). 
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In the posterior hypothalamus and thalamus of the forebrain, the areas with 
Figure 2. Representative viral tract tracing images of BAT SS-SNS feedback loops. 
(A) Low and (B) high magn fication of e microphotograp s illustrating single PRV152 (green), single H129 (red) 
and double PRV152+H129 (arrows) immunolabeling in the RPa and ROb following viral injections into IBAT. Gi, 
gigantocellular reticular nucleus; LPGi, lateral paragigantocellular nucleus; py, pyramidal tract. n=5. (C) Low and 
(D) high magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and double 
PRV152+H129 (arrows) immunolabeling in the PAG following viral injections into IBAT. 3N, oculomotor nucleus; 
Aq, aqueduct; DLPAG, dorsolateral periaqueductal gray; DpMe, deep mesencephalic nucleus; DR, dorsal raphe 
nucleus; LPAG, lateral periaqueductal gray; mlf, medial longitudinal fasciculus. (E) Low and (F) high magnification 
of the microphotographs illustrating single PRV152 (green), single H129 (red) and double PRV152+H129 (arrows) 
immunolabeling in the DM following viral injections into IBAT. 3V, third ventricle; LH, lateral hypothalamus; VMH, 
ventromedial hypothalamic nucleus. (G) Low and (H) high magnification of the microphotographs illustrating single 
PRV152 (green), single H129 (red) and double PRV152+H129 (arrows) immunolabeling in the LH following viral 
injections into IBAT. 3V, third ventricle; TC, tuber cinereum area; VMH, ventromedial hypothalamic nucleus. (I) 
Low and (J) high magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and 
double PRV152+H129 (arrows) immunolabeling in the PVH following viral injections into IBAT. AHP, anterior 
hypothalamic area, posterior part; opt; optic tract; VMH, ventromedial hypothalamic nucleus. (K) Low and (L) high 
magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and double 
PRV152+H129 (arrows) immunolabeling in the MPA following viral injections into IBAT. aca, anterior commissure; 
MnPO, median preoptic nucleus; MPO, medial preoptic nucleus. Scale bar=200 µm in (A, C, E, G, I and K) and 50 
µm in (B, D, F, H, J and L). 
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extensive percentages of double-infected neurons included the sub zona incerta (SubZI; 
13.5 ± 3.9 %; Table 1), posterior hypothalamic nucleus (PH; 11.1 ± 1.5 %; Table 1), 
dorsomedial hypothalamic nucleus (DM; 9.8 ± 2.3 %; Table 1 and Fig. 1E, F), lateral 
hypothalamic area (LH; 9.3 ± 0.6 %; Table 1 and Fig. 2G, H), paraventricular 
hypothalamic nucleus (PVH; 11.2 ± 1.8 %; Table 1 and Fig. 2I, J) and anterior 
hypothalamic area (AHA; 9.2 ± 4.3 %; Table 1). The infected neurons were more heavily 
represented in the medial parvicellular (PaMP) subnucleus within the PVH (absolute 
numbers: 137.8 ± 22.1 for PRV152-ir neurons and 129.8 ± 32.8 for H129-ir neurons; 
Table 1). The ventromedial hypothalamic nucleus (VMH) was scarcely represented only 
by a few PRV152-ir neurons by comparison with other forebrain regions (Table 1 and 
Figs. 2G; 2I) as we have seen previous (Bamshad et al., 1999; Leitner & Bartness, 2009; 
Song et al., 2008). The overall percentage of PRV152- and H129-ir posterior 
hypothalamus and thalamus double-labeled neurons was ~9.0% (Fig. 3B).  
In the anterior hypothalamus of the forebrain, the medial preoptic area (MPA), 
medial preoptic nucleus (MPO) and median preoptic nucleus (MnPO) had significantly 
higher absolute numbers of PRV152-ir neurons as compared with those infected with 
H129 (F(1,9)=60.88; P<0.05 for MPA; F(1,9)=5.67; P<0.05 for MPO and F(1,9)=9.81; 
P<0.05 for MnPO; Table 1 and Figs. 2K, L; 3B). The H129 immunostaining was 
suggestively decreased compared to PRV152 immunostaining in other forebrain areas 
such as the lateral preoptic area (LPO), anteroventral preoptic nucleus (AVPO) and 
anteroventral periventricular nucleus (AVPe) (F(1,9)=3.96; P=0.081 for LPO, F(1,9)=4.89; 
P=0.058 for AVPO and F(1,9)=5.38; P=0.057 for AVPe; Table 1). The percentage of 
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anterior hypothalamus double-labeled neurons (~3.5 %) was significantly lower than 
those in the posterior hypothalamus and thalamus, midbrain and hindbrain 
(F(3,19)=9.61; P<0.05; Fig. 3B), where there was no statistical difference between the 
numbers of PRV152/H129 colocalized neurons (Fig. 3B). 
The RPa and NTS of the hindbrain, the PAG of the midbrain, and the PVH of the 
forebrain contained the highest absolute numbers of both single- and double-labeled 
virally-infected neurons (Fig. 3A). The MPA of the forebrain had the highest absolute 
number only for PRV152 single-labeled neurons (F(1,9)=60.88; P<0.05 vs. H129; Fig. 
3A). 
Figure 3. Quantification of viral tract tracing of BAT SS-SNS feedback loops. 
(A) Brain areas with highest absolute numbers of PRV152- and H129-ir neurons. Note that the MPA contained 
predominantly SNS (PRV152) efferent output to IBAT as compared to a SS (H129) afferent input from the same fat 
pad. MPA, medial preoptic area; NTS, nucleus of the solitary tract; PAG, periaqueductal gray; PVH, paraventricular 
hypothalamic nucleus; RPa, raphe pallidus nucleus. n=5; *P<0.05 vs. PRV152. (B) Percentile quantification of 
PRV152 and H129 double-labeled (-infected) in the hindbrain, midbrain, posterior hypothalamus and thalamus, 
and anterior hypothalamus. n=5; *P<0.05 vs. hindbrain, midbrain and posterior hypothalamus and thalamus. 
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2.4.2 Experiment 2: IBAT thermogenesis, DRG c-Fos 
immunostaining of FB-labeled neurons after intra-IBAT 
CL316,243 administration 
One aim of this study was to test whether a highly selective β3-adrenoceptor 
agonist, CL316,243, stimulated facultative thermogenesis in IBAT. Compared with 
saline vehicle-treated right IBAT, intra-left IBAT CL316,243 injections significantly 
increased TIBAT within 10 min and this effect remained significant up to 60 min post-
injections (t(21)=11.73; P<0.05; Fig. 4A;). The difference in TIBAT between CL316,243- 
and saline-treated fat pads steadily increased to 0.8 °C by 10 min, then slightly dropped 
to 0.56 °C by 20 min and stabilized to 0.53 °C by 60 min (Fig. 4B). Tb did not undergo 
significant fluctuations over 60 min; however, it was significantly lower compared with 
CL316,243-induced temperature increases (t(21)=26.89; P<0.05; Fig. 4A;).  
To define which DRG were activated by BAT SNS stimulation, we pre-labeled 
DRG neurons innervating IBAT by injecting a conventional retrograde tracer FB 
followed 1 wk later by intra-IBAT injections of β3-adrenoceptor agonist CL316,243 into 
the left and saline into the right IBAT pad. c-Fos immunostaining and FB labeling in the 
DRG pseudounipolar neurons appeared largely at vertebral C1-T5 levels (Figs. 5A-H). 
CL316,243 intra-IBAT injections significantly activated C2-C4 DRG neurons ipsilateral 
to the CL316,243 injections compared with the contralateral control side (F(1,17)=4.51; 
P<0.05 for C2; F(1,23)=5.63; P<0.05 for C3 and F(1,23)=4.85; P<0.05 for C4; Figs. 5G, H). 
The c-Fos baseline level before the CL316,243 injections was approximately 4-fold lower 
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in aforementioned DRG. C4, C5 and T2 DRG contained the highest absolute numbers of 
FB-labeled neurons innervating IBAT compared with the contralateral side (F(1,23)=9.06; 
P<0.05 for C4; F(1,23)=9.48; P<0.05 for C5 and F(1,23)=6.36; P<0.05 for T2; Figs. 5G, H). 
The numbers of FB-labeled DRG neurons were significantly increased at C1-T2 
ipsilateral to the FB injections compared with those of the contralaterally FB-labeled 
neurons (F(1,11)=10.21; P<0.05 for C1; F(1,17)=8.30; P<0.05 for C2; F(1,23)=30.98; P<0.05 
for C3; F(1,23)=9.06; P<0.05 for C4; F(1,23)=9.48; P<0.05 for C5; F(1,23)=4.91; P<0.05 for 
C6; F(1,23)=4.81; P<0.05 for C7; F(1,23)=5.67; P<0.05 for T1 and F(1,23)=6.36; P<0.05 for 
T2; Figs. 5G, H). C3-C6 DRG had significantly more c-Fos+FB colocalized neurons as 
Figure 4. BAT and core temperature after intra-BAT β3-agonist injections. 
(A) The activation of IBAT thermogenesis produced by selective β3-adrenoceptor agonist CL316,243 microinjections 
intra-left IBAT in comparison with core body temperature and TIBAT after saline microinjections intra-right IBAT. (B) 
Changes in TIBAT after CL316,243 microinjections intra-left IBAT and saline intra-right IBAT over a 60-min period. 
n=12; *P<0.05 vs. saline, #P<0.05 vs. core body temperature. 
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compared with corresponding counter-DRG (F(1,23)=11.66; P<0.05 for C3; F(1,23)=12.40; 
P<0.05 for C4; F(1,23)=9.76; P<0.05 for C5 and F(1,23)=4.66; P<0.05 for C6; Figs. 5G, H). 
2.4.3 Experiment 3: Electrophysiological recordings of IBAT afferent 
nerve activity 
Three simultaneous infusions of saline vehicle along the lateral-coronal plane of 
IBAT resulted in no significant change in the rate of IBAT sensory nerve activity above 
baseline levels at 10 min or 20 min post-infusions. By contrast, three simultaneous 
intra-IBAT infusions of CL316,243 (0.2 ng/kg; same dose as used for TIBAT measures) 
significantly elevated mean IBAT sensory nerve activity within 10 min (t(19)=10.43; 
P<0.05), with peak activity at 20 min post-infusions (t(19)=12.03; P<0.05; Fig. 5I) and a 
significant interaction between drug and time post-injection (F(2,29)=42.69; P<0.05). 
2.5 Discussion 
We report here the presence of crosstalk between the SNS and SS neural 
innervation of the IBAT evidenced by the co-localization of both PRV152 and H129 
neural tract tracers especially predominately in the RPa, NTS, PAG, PVH, and MPA 
brain regions. In addition, we demonstrated for the first time that intra-IBAT 
CL316,243-triggered β3-adrenoceptor stimulation significantly increased TIBAT and 
directly activated IBAT-associated DRG neurons. Lastly, intra-IBAT CL316,243-
triggered β3-adrenoceptor stimulation also significantly elevated afferent nerve activity. 
Collectively, these data provide important insight into the distributed neural system 
integrating SNS and SS neural circuits innervating IBAT based on the demonstration of 
doubly-infected neurons (i.e., possible SNS-SS neural feedback loop neurons) and that 
these IBAT afferents are sensitive to β3-adrenoceptor stimulation/IBAT thermogenesis. 
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Figure 5. Activation of spinal afferents innervating BAT. 
Representative microphotographs of DRG at C4 vertebral level showing c-Fos immunostaining (A, D), FB labeling (B, 
E) and c-Fos+FB colocalization (C, F; arrows) after CL316,243 microinjections intra-left and saline intra-right IBAT. 
Distribution of c-Fos-ir and FB-labeled neurons in IBAT innervating DRG at C1-T4 vertebral levels contralateral (G) 
and ipsilateral (H) to CL316,243 microinjections. The total number of positively-stained neurons per ganglion can be 
estimated by multiplying the number per section by 24. n=12; *P<0.05 vs. saline counter-mate. Scale bar=50 µm. (I) 
Mean nerve activity from IBAT afferent fibers before (baseline), at 10 min and at 20 min after CL316,243 or saline 
microinjections n=5 per group. CL316,243-evoked increase in IBAT sensory nerve activity. (Below) 10 min sample 
traces of IBAT afferent fibers before and after infusion of either CL316,243 (top) or saline (bottom). *P<0.05 vs. 
saline. 
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We found overlap of SNS-SS IBAT-innervating circuits across the neuroaxis. 
Specifically, the highest overlap of dually-infected PRV152+H129 neurons was in the 
LPGi (~13%), ROb (~13%), MPB (~13%) and RPa (~13%) in the hindbrain; LPAG 
(~12%), VLPAG (~10%) in the midbrain and SubZI (~14%), PVH (~11%), PH (~11%) and 
DM (~10%) in the forebrain. All these regions previously were reported to be involved in 
the control of BAT thermogenesis [(Richard et al., 2010; Ulhoa et al., 2013); for review 
see: (Morrison et al., 2014; Bartness et al., 2010b)]. Note that the number of double-
labeled neurons likely was underestimated because infection of a neuron with one virus 
can, in principle, reduce the susceptibility to infection by a second virus [phenomenon 
of exclusion (Kim, Enquist, & Card, 1999)]. Due to the unpredictable time interval for 
each virus to reach each specific area, the neurons on both ascending and descending 
pathways to IBAT may not have necessarily showed dual infections despite the selection 
of inoculation/post-inoculation time points that optimized the double-virus technique 
by matching viral progression rates through the neural axis as closely as possible [for 
review see: (ter Horst, 2000)]. 
Despite predominantly equal SNS and SS representation in many brain regions, 
several brain regions had differing amounts of SNS efferent output/SS afferent input to 
and from IBAT. That is, the LPAG, DLPAG and DR in the midbrain had largely SNS 
output compared with SS input. The PAG receives afferent fibers not only from the 
parabrachial nucleus and RPa (Mantyh, 1982), which are critical for the proper 
thermoregulatory IBAT function [(Kobayashi & Osaka, 2003); for review see: (Morrison 
et al., 2014)], but also from the spinal cord (Pechura & Liu, 1986). We previously 
reported that the PAG sends SNS efferents ultimately to white adipose tissue (WAT) in 
Siberian hamsters (Bamshad, Aoki, Adkison, Warren, & Bartness, 1998; Nguyen et al., 
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2014; Song, Jackson, Harris, Richard, & Bartness, 2005) as did others in laboratory rats 
(Adler, Hollis, Clarke, Grattan, & Oldfield, 2012). Moreover, we recently found that the 
dorsomedial PAG was among several other sites with predominantly SNS efferent 
output to the inguinal WAT (IWAT) as compared with SS input from IWAT (Ryu & 
Bartness, 2014) suggesting differential SNS nodes to different fat pads within the PAG. 
Regarding the DR, a profound IBAT thermogenic response is triggered with DR 
electrical stimulation (Dib, Rompre, Amir, & Shizgal, 1994); thus, it is not surprising to 
Figure 6. Diagram of BAT SS-SNS feedback loops. 
A diaphragmatic representation of the efferent sympathetic (green arrows) and afferent sensory (red arrows) brain-
IBAT neural feedback circuit for control of IBAT functions. BAT, brown adipose tissue; C4-T2, cervical and thoracic 
vertebral level; DH, dorsal horn; DRG, dorsal root ganglia; IML, intermediolateral cell column; MPA, medial preoptic 
area; NTS, nucleus of the solitary tract; PAG, periaqueductal gray; PVH, paraventricular hypothalamic nucleus; RPa, 
raphe pallidus nucleus; SG, sympathetic ganglia. 
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see the DR as a component of the SNS outflow to IBAT with our viral neurocircuit 
labeling method.  
We found the MPA, MPO and MnPO were mostly involved with the SNS outflow 
to, but not the SS inflow from, IBAT and these sites are involved in the IBAT 
thermoregulatory SNS responses to skin cooling (Nakamura & Morrison, 2008a). This 
greater SNS outflow from the MPA than SS inflow supports our previous finding of 
relatively sparse MPA H129-infected neurons from IBAT compared with many other 
areas (Vaughan & Bartness, 2012), but impressive PRV152-infected neurons (Bamshad 
et al., 1999; Leitner & Bartness, 2009; Song et al., 2008). Despite the relatively small 
number of MPA-MPO-MnPO SS circuit neurons, this by no means necessarily lessens 
its contribution to thermoregulatory signaling from the skin (Nakamura & Morrison, 
2008a, 2008b) as the MPA-SS innervation in the present study mainly reflects the SS 
pathway originating from the IBAT. IBAT increases thermogenesis in response to cold 
exposure in decerebrate rats. However, where most of the midbrain and all of the 
forebrain are surgically separated from the hindbrain/peripheral nervous systems 
(Nautiyal et al., 2008), the necessity of SS input to the MPA or other rostral brain sites 
combined with the presence of PRV152+H129 dually-infected neurons in the hindbrain 
indicates that, unlike some of the models proposed for the BAT SNS thermoregulatory 
control with the MPA as the ‘origin’ of the descending signals and recipient of the 
ascending afferent information [e.g., (Morrison, Madden, & Tupone, 2012)], SS input 
may crosstalk with central SNS outflow across the neuroaxis including the hindbrain 
(Nautiyal et al., 2008). Indeed, this notion is supported by thermal sensory inputs to the 
midbrain and caudal hindbrain implicated in the thermal response to skin cooling and 
thermal control in general [e.g., (Uno et al., 2003)]. 
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Table 1. Distribution of sympathetic (PRV152) and sensory (H129) neurons across the neuraxis 
 PRV152 H129 PRV152+H129 
Percentage of 
PRV152+H129 
Hindbrain     
7N 67.4±12.1 57.6±19.5 11.8±3.0 10.4±1.3 
10N 16.0±8.2 14.5±1.2 2.0±1.6 5.7±4.7 
12N 24.3±5.2 17.0±8.0 0.7±0.3 1.9±1.0 
PnO 38.0±16.0 27.4±9.6 6.4±2.5 11.3±1.1 
PnC 51.4±15.1 42.6±8.1 9.2±2.5 10.6±1.9 
SuVe 74.2±20.8 59.6±16.1 13.2±2.4 12.1±1.8 
MPB 36.6±10.3 40.5±8.4 7.6±1.5 12.7±1.1 
LPBI 6.3±2.9 5.3±1.6 1.7±0.8 7.3±4.7 
LPBC 23.6±7.1 13.4±5.3 3.0±1.2 9.5±4.3 
MPBE 11.3±5.6 11.3±4.7 2.0±0.7 8.0±2.6 
LC 29.8±9.9 28.3±5.7 5.0±1.5 8.5±2.4 
Bar 16.3±6.6 9.7±4.6 3.8±1.2 11.6±4.8 
Pr5 29.0±13.3 26.8±9.6 5.5±2.3 11.3±0.8 
LDTg 13.3±4.6 4.3±0.7 1.7±0.7 12.3±7.0 
Mo5 18.7±3.3 20.7±1.1 3.7±0.5 10.2±1.0 
RMg 83.8±25.9 87.2±17.7 17.2±4.1 11.4±1.2 
RPa 159.2±34.0 148.8±41.6 36.2±9.2 12.6±1.1 
ROb 154.5±55.9 116.0±14.1 30.5±5.0 12.9±1.4 
Gi 52.8±28.8 39.0±13.5 6.2±3.0 6.4±2.2 
LPGi 31.0±6.6 29.0±6.8 7.0±1.3 13.0±1.2 
DPGi 42.0±17.3 42.3±16.5 7.3±2.8 8.5±1.0 
GiV 108.0±19.7 127.2±32.4 19.0±3.0 9.2±1.0 
PCRt 14.0±4.1 10.7±3.9 1.3±0.5 4.6±2.0 
IO 152.7±41.6 129.3±15.0 25.7±6.1 9.8±1.8 
LRt 120.7±36.1 96.0±24.0 18.7±2.9 9.4±1.0 
MdV 59.3±39.9 43.0±18.0 9.0±5.9 6.8±3.4 
NTS 275.7±60.4 201.2±58.9 33.4±4.2 7.3±1.4 
SolC 28.3±5.2 21.0±4.7 5.2±1.1 10.5±2.1 
SolCe 7.2±2.8 5.3±2.0 1.3±0.4 9.3±2.6 
SolDL 31.8±15.2 27.9±14.8 4.7±1.9 7.7±1.7 
SolG 21.7±10.9 15.3±4.5 2.8±0.4 7.1±2.3 
SolI 7.4±3.0 4.8±1.5 1.2±0.2 9.3±3.1 
SolIM 25.3±8.8 19.5±4.1 3.7±1.3 7.9±2.2 
SolM 97.3±12.0 66.0±14.5 12.7±4.3 7.2±2.0 
SolV 11.7±3.4 10.8±3.5 2.0±0.2 8.6±1.3 
SolVL 45.8±18.3 32.1±10.2 6.0±2.8 7.5±2.4 
Pr 25.5±11.2 15.0±6.6 3.8±2.8 6.2±3.1 
Midbrain     
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PAG 260.6±51.3 109.2±28.8 32.0±5.8 9.6±1.5 
DMPAG 32.4±9.3 12.2±4.7 2.8±1.11 6.3±1.2 
DLPAG 26.0±6.1 8.4±2.6* 1.8±0.7 5.1±1.6 
LPAG 60.0±11.5 30.0±6.9* 8.8±1.3 11.5±2.1 
VLPAG 54.8±11.6 18.2±6.0 6.4±1.4 10.3±1.8 
DR 23.6±6.7 7.0±2.2* 2.4±0.6 7.7±2.4 
DpMe 54.3±20.3 19.0±6.4 6.0±1.9 8.5±3.1 
R 18.0±5.5 9.6±2.9 2.6±0.2 9.4±3.3 
VTA 32.5±12.7 13.5±4.6 3.5±1.2 7.6±2.8 
Forebrain     
MPA 79.8±8.9 6.4±3.0* 2.2±1.0 3.0±1.7 
MPO 36.4±13.8 6.8±2.6* 1.4±0.9 5.0±3.0 
MnPO 17.4±5.2 0.8±0.8* 0.2±0.2 2.0±2.0 
LPO 23.8±10.5 1.5±0.8 0.8±0.4 1.7±1.0 
AVPO 32.6±9.5 7.8±5.9 1.4±1.0 2.8±1.7 
AVPe 23.5±7.9 3.3±1.8 1.3±0.8 3.3±2.3 
SCh 13.5±6.9 4.5±1.7 0.5±0.4 1.2±1.0 
AHA 7.4±2.2 3.8±2.2 1±0.4 9.2±4.3 
AHP 22.8±9.1 9.8±5.5* 2.4±1.3 5.8±2.4 
PVH 277.4±55.5 237.8±58.7 48.8±8.7 11.2±1.8 
PaAP 15.0±4.9 14.8±7.2 3.5±1.7 10.7±3.2 
PaDC 30.6±7.3 36.4±11.3 6.2±1.7 8.9±3.1 
PaMP 137.8±22.1 129.8±32.8 23.6±4.2 10.4±1.7 
PaMM 12.2±4.9 7.2±2.3 1.8±1.1 6.8±4.5 
PaLM 36.0±6.8 35.3±10.7 5.8±1.7 8.5±1.4 
PaV 16.7±2.5 16.3±4.2 3.3±1.4 12.6±5.8 
PaPo 22.7±12.0 25.4±12.5 7.6±5.2 8.4±2.3 
Arc 19.6±7.1 8.2±2.1 2.0±0.9 5.9±2.6 
LH 101.6±20.8 40.0±3.9 11.8±1.7 9.3±0.6 
VMH 6.4±4.1 0 0 0 
DM 83.3±31.8 30.3±5.8 8.7±1.7 9.8±2.3 
PH 39.8±12.9 15.8±1.5 5.0±1.1 11.1±1.5 
ZI 18±11.0 8.6±4.5 1.2±0.8 2.6±1.7 
SubZI 31.6±4.6 22.4±8.9 6.8±2.0 13.5±3.9 
 
Data are expressed as mean number of neurons per brain region ± SEM (n=5), *p<0.05 vs. PRV152. 7N, facial 
nucleus; 10N, dorsal motor nucleus of the vagus nerve; 12N, hypoglossal nucleus; AHA, anterior hypothalamic area, 
anterior part; AHP, anterior hypothalamic area, posterior part; Arc, arcuate nucleus; AVPe, anteroventral 
periventricular nucleus; AVPO, anteroventral preoptic nucleus; Bar, Barrington's nucleus; DLPAG, dorsolateral 
periaqueductal gray; DM, dorsomedial hypothalamic nucleus; DMPAG, dorsomedial periaqueductal gray; DPGi, 
dorsal paragigantocellular nucleus; DpMe, deep mesencephalic nucleus; DR, dorsal raphe nucleus; Gi, gigantocellular 
reticular nucleus; GiV, gigantocellular reticular nucleus, ventral part; IO, inferior olive; LC, locus coeruleus; LDTg, 
laterodorsal tegmental nucleus; LH, lateral hypothalamic area; LPAG; lateral periaqueductal gray; LPBC, lateral 
parabrachial nucleus, central part; LPGi, lateral paragigantocellular nucleus; LPO, lateral preoptic area; LPBI, lateral 
parabrachial nucleus, internal part; LRt, lateral reticular nucleus; MdV, medullary reticular nucleus, ventral part; 
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MnPO, median preoptic nucleus; Mo5, motor trigeminal nucleus; MPA, medial preoptic area; MPB, medial 
parabrachial nucleus; MPBE, medial parabrachial nucleus external part; MPO, medial preoptic nucleus; NTS, nucleus 
of the solitary tract; PaAP, paraventricular hypothalamic nucleus, anterior parvicellular part; PaDC, paraventricular 
hypothalamic nucleus, dorsal cap; PAG, periaqueductal gray; PaLM, paraventricular hypothalamic nucleus, lateral 
magnocellular part; PaMM, paraventricular hypothalamic nucleus, medial magnocellular part; PaMP, paraventricular 
hypothalamic nucleus, medial parvicellular part; PaPo, paraventricular hypothalamic nucleus, posterior part; PaV, 
paraventricular hypothalamic nucleus, ventral part; PCRt, parvicellular reticular nucleus; PH, posterior hypothalamic 
area; PnC, pontine reticular nucleus, caudal part; PnO, pontine reticular nucleus, oral part; Pr, prepositus nucleus; 
Pr5, principal sensory trigeminal nucleus; PVH, paraventricular hypothalamic nucleus; R; red nucleus; RMg, raphe 
magnus nucleus; ROb, raphe obscurus nucleus; RPa, raphe pallidus nucleus; SCh, suprachiasmatic nucleus; SolC, 
nucleus of the solitary tract, commissural part; SolM, nucleus of the solitary tract, medial part; SolVL, nucleus of the 
solitary tract, ventrolateral part; SubZI, sub zona incerta; SuVe, superior vestibular nucleus; VLPAG, ventrolateral 
periaqueductal gray; VMH, ventromedial hypothalamic nucleus 
 
The highest percentage of double-labeled neurons reached ~13.0 % in several 
hindbrain, midbrain and hypothalamic regions. Compared with more than half of 
double-labeled SNS-SS feedback neurons in many of the same and other brain areas 
following injections of PRV152 and H129 into the IWAT (Ryu & Bartness, 2014), this 
lower rate of double-labeled neurons could reflect a lesser feedback from BAT versus 
WAT and/or may reflect a lesser number of BAT functions requiring neural feedback 
compared to WAT. That is, the SNS and SS innervations of BAT may primarily reflect its 
function in thermogenesis, whereas a neural feedback for its role in lipid and glucose 
clearance has not been, to our knowledge, tested and may not require neural feedback 
[for review see: (Cannon & Nedergaard, 2004b)]. By contrast, WAT stores/releases lipid 
and adipokines and has afferents sensitive to both increases in SNS drive (Bartness, 
Shrestha, Vaughan, Schwartz, & Song, 2010) and to leptin (Murphy et al., 2013), that 
latter perhaps conveying the amounts of stored lipid via this neural conduit (Bartness, 
Liu, Shrestha, & Ryu, 2014b).  
We previously demonstrated that an intact SS innervation of BAT is necessary for 
normal acute cold exposure-induced IBAT thermogenic increases (Vaughan & Bartness, 
2012). To our knowledge, no biochemical signal from BAT responsible for the activation 
of local SS nerve terminals has been identified at this time. In this regard, we previously 
reported (Song et al., 2009) that the firing frequency of decentralized SS nerve fibers 
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innervating IWAT was markedly increased when anesthetized hamsters were injected 
with the glucoprivic agent 2-deoxy-D-glucose known to drive SNS outflow and lipolysis 
(Brito et al., 2008). Those findings suggest that factors associated with activation of β3-
adrenoceptors, such as fatty acids and glycerol, might activate BAT afferents. The 
necessity of lipolysis for the full effect of SNS/NE-induced BAT thermogenesis is 
demonstrated in brown adipocytes harvested from mice where ablation of all protein 
kinase A phosphorylation sites on the adipocyte intracellular protein perilipin A result 
in an abolished NE-induced lipolytic response and these mice exhibit a severely blunted 
(~70%) decrease in NE-induced thermogenesis in vivo (Souza et al., 2007). Other 
plausible functions for BAT SNS-SS feedback loops include IBAT afferents directly 
sensing changes in TIBAT due to increases in SNS drive and/or to SNS-mediated marked 
increases in IBAT blood flow seen in cold-exposed Siberian hamsters, and laboratory 
rats and mice [~15-100 fold or more; (Baron et al., 2012; Foster & Frydman, 1978; 
Puchalski, Bocker, Heldmaier, & Langefeld, 1987)]. Such a role for SS feedback in the 
control of local blood flow has been repeatedly proposed [e.g., (Holzer, 2006; Loesch, 
2002)]. Therefore, given that our FB tracing revealed several DRG (C4, C5 and T2) with 
the highest numbers of projections to IBAT, this may suggest contribution of more than 
one population of SS nerve bundles with heterogeneous capacity to sense the changes in 
local temperature, as observed in other organs (Borzan, LaGraize, Hawkins, & Peng, 
2005), in blood flow and/or lipolysis-related factors. 
In order to further understand both the functional and neuroanatomical basis 
underlying SNS-SS interaction relative to IBAT thermogenesis, we injected CL316,243, a 
highly selective and potent β3-adrenoceptor intra-IBAT to determine the vertebral levels 
at which DRG sensory neurons innervating IBAT are activated by β3-adrenoceptor 
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stimulation. Our goal was to approximate the naturally-occurring stimulation of these 
receptors by the SNS release of NE parenchymally, but do so specifically to β3-
adrenoceptors using CL316,243. CL316,243 significantly increased TIBAT within 10 min 
after injection, activated C2-C4 DRG as evidenced by significantly increased c-Fos 
immunolabeling in DRG neurons pre-labeled with FB ipsilateral to the injection 
compared with the contralateral control side. Functionally, CL316,243 intra-IBAT 
injections significantly increased TIBAT and afferent nerve activity within the same 20 
min time frame. 
Collectively, our results show persuasive evidence of the BAT SNS-SS neural 
feedback loops with a coordinated or multiple redundant controls of thermoregulatory 
functions. In addition, we demonstrated that sympathetic stimulation directly activates 
BAT-associated DRG, and hence sensation, perhaps in relation to its thermogenic 
and/or lipolytic response. Finally, the approach of direct, intra-IBAT injection combined 
with c-Fos-ir in DRGs and/or electrophysiologic assessment of BAT afferent activity 
provides a model system with which to determine BAT sensory nerve activators 
analogous to our study of WAT afferents using the same methodologies (Murphy et al., 
2013). 
2.6 Author contributions 
T.J.B, V.R., Y.L., and C.V. designed the neuroanatomical tracing experiments. 
V.R. performed the tracing, the BAT temperature recording, and DRG immunostaining 
experiments. T.J.B. and J.G. designed and J.G. performed the neurophysiological BAT 
afferent recording experiments.  
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3.1 Abstract 
Objective: Metabolic challenges, such as a cold environment, stimulate 
sympathetic neural efferent activity to white adipose tissue (WAT) to drive lipolysis, 
thereby increasing the availability of free fatty acids as one source of fuel for brown 
adipose tissue (BAT) thermogenesis. WAT is also innervated by sensory nerve fibers that 
network to metabolic brain areas; moreover, activation of these afferents is reported to 
increase sympathetic nervous system outflow. However, the endogenous stimuli 
sufficient to drive WAT afferents during metabolic challenges as well as their functional 
relation to BAT thermogenesis remain unknown. Method: We tested if local WAT 
lipolysis directly activates WAT afferent nerves, and then assessed whether this WAT 
sensory signal affected BAT thermogenesis in Siberian hamsters (Phodopus sungorus). 
Results:  2-deoxyglucose, a sympathetic nervous system stimulant, caused β-
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adrenergic receptor dependent increases in inguinal WAT (IWAT) afferent 
neurophysiological activity. In addition, direct IWAT injections of the β3-AR agonist 
CL316,243 dose-dependently increased: 1) phosphorylation of IWAT hormone sensitive 
lipase, an indicator of SNS-stimulated lipolysis, 2) expression of the neuronal activation 
marker c-Fos in dorsal root ganglion neurons receiving sensory input from IWAT, and 
3) IWAT afferent neurophysiological activity, an increase blocked by antilipolytic agent 
3’5-dimethylpyrazole. Finally, we demonstrated that IWAT afferent activation by 
lipolysis triggers interscapular BAT thermogenesis through a neural link between these 
two tissues. Conclusions:  These data suggest IWAT lipolysis activates local IWAT 
afferents triggering a neural circuit from WAT to BAT that acutely induces BAT 
thermogenesis.  
3.2 Introduction 
Adipose tissue is connected to the CNS via afferent and efferent nerve fibers 
directly innervating each fat depot. While adipose efferents are entirely 
catecholaminergic (Youngstrom & Bartness, 1995), adipose afferents are primarily 
unmyelinated c-fibers—positive for substance p and calcitonin gene-related peptide 
(CGRP)—and receptive to a variety of stimuli (Giordano et al., 1996). Although the 
anatomical reality of WAT afferents was initially discovered by Fishman and Dark 
(Fishman & Dark, 1987), the first functional role of neural afferents arising from white 
adipose tissue (WAT) was demonstrated by Niijima (Niijima, 1998) by injecting the 
adiposity hormone leptin directly into WAT then measuring neurophysiological activity 
in decentralized (sensory) nerve fibers connected to the tissue. These results have been 
interpreted to suggest that local leptin, secreted by WAT in proportion to adipocyte size 
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and number, is transduced as a neural signal proportional to the amount of stored 
energy (Caro, Sinha, Kolaczynski, Zhang, & Considine, 1996). However, WAT afferents 
also increase their neurophysiological activity in response to adenosine and 
bradykinin—indicating an active role of these afferents in blood pressure sensation (Shi 
et al., 2012). Despite the variety of signals sensed by WAT afferents, each 
neurophysiologically effective stimulus similarly increases sympathetic nervous system 
(SNS) drive to WAT and other tissues in a positive feedback WAT-brain-SNS reflex 
circuit termed the “adipose afferent reflex” (AAR) (Niijima, 1999; Shi et al., 2012). 
Indeed, our viral tracing studies expose the neuroanatomical framework for this AAR 
wherein WAT afferents are networked to WAT efferents throughout metabolically 
relevant CNS nuclei (e.g. intermediolateral nucleus of the spinal cord, nucleus of the 
solitary tract, periaqueductal gray, dorsomedial, lateral, arcuate and paraventricular 
hypothalamus). (Bartness & Song, 2007b). In addition, these studies reveal a high 
degree of neuroanatomical overlap between neuronal populations at multiple peripheral 
and central levels of the neuraxis including WAT sensory and brown adipose tissue 
(BAT) SNS innervation (Song et al., 2009; Vaughan et al., 2011). Thus, functional and 
neuroanatomical sensory-motor links between WAT and the SNS have been established 
(Murphy et al., 2013; Ryu & Bartness, 2014); however, the sensitivity of WAT afferents 
to local lipolytic activity of the tissue and the potential for these afferents to induce heat 
production in BAT have not been fully investigated. 
Among all functions of WAT, its catabolism and subsequent efflux of stored 
energy is a rapid and necessary process for the release of fuels when energy demand is 
high with an evolutionarily highly conserved mechanism across species including non-
mammals (Bartness et al., 2014a; Migliorini et al., 1992). During an energetic challenge 
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such as cold exposure, norepinephrine released by axon terminals of post ganglionic 
SNS neurons binds β3-adrenorecptors (β3-AR)—present on adipocytes (Lafontan et al., 
1997)—initiating a lipolytic cascade that is dependent on the phosphorylation of 
hormone sensitive lipase (HSL) and leads to the preferential release of long-chain free-
fatty acids (FFAs) and glycerol as useable energy (Bartness & Song, 2007a; Belfrage et 
al., 1981). Peripheral injection of 2-deoxyglucose (2DG), a glucoprivic and thus 
sympathomimetic drug, causes SNS dependent mobilization of triglycerides from WAT 
and also increases WAT afferent activity within minutes (Song et al., 2009). This efflux 
of substrates from WAT occurs locally first, then is circulated throughout the body/brain 
and oxidized as fuel when glucose is not readily available/sufficient for energy demand 
(Lass, Zimmermann, Oberer, & Zechner, 2011) or converted to heat via uncoupled 
oxidative phosphorylation by BAT, a tissue similarly dependent on SNS innervation to 
trigger thermogenesis. Thus, we hypothesize that WAT afferents activated by 
glucoprivation may be sensing locally released lipolytic products thereby transducing 
lipolysis into rapid neural signals communicated to the CNS (Song et al., 2009). If this is 
true, then lipolysis sensation by WAT afferents likely induces BAT thermogenesis 
because 1) lipolysis provides substrates that are required for BAT thermogenesis 
(Haemmerle et al., 2006; Labbé et al., 2015) and 2) the strikingly similar patterns of 
WAT afferent and BAT efferent neural connectivity (Song et al., 2009; Vaughan et al., 
2011). To investigate these hypotheses, we first tested if WAT lipolysis and/or its 
products were sufficient to drive spinal afferent nerves receiving sensory input from 
subcutaneous inguinal WAT (IWAT), then we tested whether stimulation of lipolysis 
sensing IWAT afferents triggers interscapular BAT (IBAT) thermogenesis. 
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3.3 Methods and Materials 
3.3.1 Animals 
Adult male Siberian hamsters (Phodopus sungorus; ~3-4 months old) from our 
breeding colony were individually housed in a long day photoperiod (16h:8h light:dark 
cycle; at 22 ± 2 ºC) with free access to water and rodent chow. Siberian hamsters were 
used because of the expanding literature characterizing the anatomy of their neuro-
adipose axis (Bartness et al., 2014a) and the apparent conservation of adipocyte 
catabolism among mammalian species (Migliorini et al., 1992). All procedures were 
approved by the Georgia State University Institutional Animal Care and Use Committee 
and are in accordance with Public Health Service and United States Department of 
Agriculture guidelines. 
3.3.2 Neurophysiological recordings of IWAT afferent nerve activity 
Siberian hamsters (n=13, unilateral recordings; n=16, bilateral recordings) were 
anesthetized with ketamine (100 mg/kg)/xylazine (10 mg/kg, i.p.), then dissected by a 2 
cm dorsal ventral incision. IWAT and connective tissue were resected and isolated from 
surrounding tissue, after which the nerves innervating right and/or left IWAT were 
exposed. Single nerve bundles from these WAT nerves were isolated and severed 
proximal to the electrode placement site to disconnect efferent fibers, finally the afferent 
ends of decentralized nerves were placed on platinum-iridium (32-gauge) hook 
electrodes. A petroleum jelly mineral oil mixture (1:1) was applied to the sites to 
completely surround the electrode/nerve connection, then warm mineral oil was pooled 
into the recording area to insulate electrical noise, prevent aqueous infusions from 
leaking to other tissue, secure the nerve on the electrode, and reduce drying of tissue. A 
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steady anesthetic plane was maintained with supplemental ketamine (50 mg/kg, s.c.) by 
examining toe pinch and eye blink responses throughout the recordings.  
For unilateral recordings, baseline neurophysiological spike activity in IWAT 
afferents was recorded for 5 min as reported (Song et al., 2009), then hamsters received 
either propranolol (40 mg/kg, i.p.) or sterile saline vehicle (i.p.) and spikes were 
recorded for an additional 5 min. Finally, 2DG (500 mg/kg, s.c.) was administered and 
IWAT afferent activity was measured for an additional 10 min.  
For bilateral recordings, decentralized nerves from left and right IWAT were each 
placed on electrodes then three sharp stainless steel needles connected with Silastic 
tubing to Hamilton microsyringes (Hamilton Company, Reno, NV) were inserted into 
left and right IWAT along the lateral-coronal plane spaced 4-5 mm apart at a depth of 
approximately 4-5 mm each (diagram of procedure, Fig. 8a). Ten minutes of basal 
electrical activity was measured followed by 15 µl of the β3 adrenergic receptor agonist 
CL316,243 (CL, 0.2 ng/kg or 0.1 ng/kg) and saline vehicle was infused simultaneously 
into the opposite IWAT pad at a rate of 3.0 µl/min for 5 min. CL stimulation is 
commonly used to simulate SNS activity to adipose tissue and reliably induces lipolysis 
in vivo and in vitro (Atgie, Faintrenie, Carpene, Bukowiecki, & Geloen, 1998b; 
Umekawa, Yoshida, Sakane, & Kondo, 1997). A separate cohort of animals was 
pretreated with the antilipolytic drug 3’5-dimethylpyrazole (DMP, 12 mg/kg, i.p.) 
(Gerritsen & Dulin, 1965; Locci-Cubeddu & Bergamini, 1983; Masiello et al., 2002) 20 
min before IWAT infusions of CL (0.2 ng/kg) and saline. Eicosopentanoic acid (EPA) 
and arachidonic acid (AA) are both highly mobilized from adipose tissue during 
stimulated-lipolysis at ratios to other mobilized FAs seemingly conserved across 
species(Conner, Lin, & Colvis, 1996; Raclot & Groscolas, 1993). Thus, EPA and AA were 
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used as representative FAs—of potentially many more FA species—that may signal acute 
and local lipolysis to WAT afferents. Doses for EPA[2.94 µM in 15 µl Tocrisolve, ~8.91 
mg/kg] and AA[0.27 µM in 15 µl Tocrisolve, ~0.81 mg/kg] were calculated from studies 
that measured net output of lipolytic products from adipose fragments in rats (Raclot & 
Groscolas, 1993; Raclot et al., 1995); accordingly, physiologically relevant levels of EPA 
and AA were injected into WAT to assess whether lipolytic products stimulate WAT 
afferents directly. Infusions of drug or vehicle were counterbalanced by side to control 
for possible side bias of IWAT afferent innervations.  
Extracellular signals were amplified 10000 times with a differential AC amplifier 
set to low pass filter 100 Hz and high pass filter 1000 Hz (Model 1700; A-M Systems, 
Sequim, WA). Analog signals were visualized on an oscilloscope (Model 2530, BK 
Precision, Yorba Linda, CA), audio analyzer (Model 74-30-1; FHC, Bowdoin, ME), and 
digitized through a Digidata data acquisition system (Model 1440a; Molecular Devices, 
Sunnyvale, CA) at a 20,000 Hz sampling rate.  Recordings were captured with 
accompanying Clampex 10.3 software and analyzed for the number of spikes based on a 
voltage threshold two standard deviations above mean non-signal noise via Clampfit 
10.3 data analysis software package. All counted waveforms were visually screened, and 
non-physiological noise detected with the set threshold was easily identified and 
removed from analysis. Percentage change from baseline nerve activity was calculated 
for 10 min bins for each nerve recording session, then the difference between IWAT 
afferent activities from CL injected pads and saline injected pads was calculated and 
used for statistical analysis. 
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3.3.3 Western blot analysis of lipolysis induced by CL 
Using an identical infusion protocol to bilateral electrophysiology experiments, 
but without IWAT afferent dissection/dissociation from the CNS, CL (0.1 ng/kg or 0.2 
ng/kg) was infused into one IWAT pad simultaneously, while saline vehicle was infused 
into the contralateral IWAT pad. Animals receiving a high dose of CL (0.2 ng/kg) were 
pretreated with either DMP (20 min prior, 12 mg/kg, i.p.) or saline vehicle, and animals 
receiving a lower dose of CL (0.1 ng/kg) received no pretreatment. Fifteen minutes after 
the start of bilateral infusions (15 µl each pad, 3 loci, 3.0 µl/min for 5 min), ~100 mg of 
each IWAT pad was quickly removed, snap frozen in liquid nitrogen to preserve protein, 
then stored at -80 oC until analysis by Western blot.  
Frozen adipose tissue samples were homogenized using microcentrifuge tubes 
containing 0.5 mm zirconium oxide beads homogenization buffer containing 50 mM 
HEPES, 100 mM NaCl, 10 % SDS, 2 mM EDTA, 0.5 mM DTT, 1 mM benzamidine, 
protease inhibitor cocktail (Calbiochem, EMD Chemicals, Gibbstown, NJ), and 
phosphatase inhibitor cocktail (Thermo Fischer Scientific, Rockford, IL) at a ratio of 1:2 
tissue weight (mg): homogenization buffer (μl). The samples were agitated 2 X 1 min 
using a bullet blender tissue homogenizer and then centrifuged at 13,000 g for 10 min at 
4 °C. The infranatant was collected, aliquoted and stored at -80 °C until protein content 
was determined. Samples were diluted 1:10 in dH2O and the protein content of the 
tissue extract was determined using the bicinchoninic acid protein assay kit (Thermo 
Fisher Scientific, Rockford, IL). Samples containing 10 μg of protein were mixed with 
loading buffer and heated at 95 °C for 5 min, electrophoresed on a low-bis SDS-
PAGE[10 %: 0.08 % acrylamide:bis] and transferred to polyvinylidene difluoride 
membranes. Membranes were cut in half so that immunoblotting could be done on 
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duplicate lanes with different antibodies from the same gel. Cut membranes were 
incubated in Tris buffered-saline (TBS) with 4 % nonfat dry milk and 0.3 % Tween 
blocking solution for 2 h, then incubated in primary antibody at 4 °C  (anti-ATGL, anti-
HSL, anti-phospho-HSL, anti-beta-actin, 1:1000; Cell Signaling Technology, Danvers, 
MA) in TBS-4 %milk-0.3 % Tween for 2 days. Immunoblots were rinsed 4 X 5 min in 
TBS-Tween (TBST) and then incubated with secondary antibody (Anti-rabbit IgG HRP-
linked antibody, 1:1000; Cell Signaling Technology, Danvers, MA) for 2 h at room 
temperature. The immunoblots were rinsed 3 X 10 min in TBST and then incubated 
with LumiGLO chemiluminescent kit (Cell Signaling Technology, Danvers, MA) to 
reveal bands. 
3.3.4 Fast Blue (FB) labeling and CL administration 
Siberian hamsters (n = 10) were anesthetized with ketamine/xylazine (100 
mg/kg, 10 mg/kg; i.p.) and ventral lateral 2 cm incisions were made to expose both 
IWAT pads. The neuronal tracer FB (1.0 %; EMS-CHEMIE GmbH, Gross-Umstadt, 
Germany) was injected with a microsyringe into eight separate loci (2 µl/locus) of the 
left and right IWAT. After the last injection, the incision was closed with sterile wound 
clips and ketofen (5 mg/kg, s.c.; Fort Dodge Animal Health, Fort Dodge, IA) was 
administered for 3 d postinjection to minimize postoperative discomfort. 
One week later, CL (0.2 ng/kg in 0.9 % sterile saline) was injected into one IWAT 
pad across eight separate loci with nearly simultaneous intra-contralateral IWAT 
injections of the saline vehicle (2 μl/locus for a total of 16 μl) served as a within animal 
control. Injections of drug or vehicle were counterbalanced by side to control for 
possible side bias of IWAT afferent innervations. The skin was gently pinched closed, 
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and sterile saline-soaked gauze was laid over top of the incision site for 60 min until 
hamsters were sacrificed and DRGs processed for c-Fos immunohistochemistry.  
3.3.5 Tissue fixation and c-Fos immunostaining on DRGs 
Hamsters were overdosed with pentobarbital sodium (Sleep Away; 300 mg/kg) 
and transcardially perfused with 75 ml of 0.9 % heparinized saline followed by 150 ml 
4.0 % paraformaldehyde in 0.1 M PBS, pH 7.4, directly into the aorta. The DRGs (T12-
L2) were extracted, the epineurium debrided and postfixed in the same fixative for 15 
min at 4 °C, then transferred to a 18.0 % sucrose solution in 0.1 M PBS with 0.1 % 
sodium azide and stored at 4 °C until they were sectioned at 20 µm on a freezing 
microtome. Sections were received directly onto slides (Superfrost Plus, VWR 
International) in three series with every fourth section on the same slide. This procedure 
yielded ~24 sections with each slide containing eight sections. Thus, an estimated total 
neuronal number per ganglion could be obtained by multiplying the number per section 
by 24 or averages here by 8. 
For DRG c-Fos immunostaining on slides, sections were rinsed in 0.1 M PBS (2 x 
15 min) followed by 1 h blocking in 5.0 % normal horse serum (NHS; Vector 
Laboratories) and 0.3 % Triton X-100 in 0.1 M PBS. Sections were then incubated in 
primary rabbit anti-c-Fos (1:500; sc-52; Santa Cruz Biotechnology) antibody with 10.0 
% NHS and 0.3 % Triton X-100 in 0.1 M PBS overnight. Next, the sections were 
incubated in secondary donkey anti-rabbit Cy3 (1:200; Jackson ImmunoResearch) for 3 
h, rinsed with 0.1 M PBS (3 x 15 min) and coverslipped with ProLong Gold Antifade 
Reagent (Life Technologies). All steps were performed at room temperature. 
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3.3.6 Brown fat transponder implantation, temperature recordings, 
and acute surgical denervation of IWAT  
Siberian hamsters (n = 36) were anesthetized with ketamine/xylazine (100 
mg/kg, 10 mg/kg, i.p.) and a dorsal 2 cm interscapular incision was made to expose 
IBAT. One  electronic transponder (Bio Medic Data Systems) with a built-in 
temperature sensor was gently implanted under one IBAT pad of each hamster, the 
temperature of which was read with a handheld DAS-7007R scanner (Bio Medic Data 
Systems) as we have used successfully previously (Brito et al., 2007; Ryu, Garretson, 
Liu, Vaughan, & Bartness, 2015a; Song et al., 2008). The incision was closed with sterile 
wound clips. 
After two weeks of recovery, hamsters were again anesthetized with 
ketamine/xylazine (100 mg/kg, 10 mg/kg, i.p.) then a ventral lateral 3 cm incision was 
made to expose right IWAT. Nerves innervating the ventral portion of IWAT were either 
left intact, or surgically destroyed (Vaughan et al., 2014) to test whether WAT lipolysis 
sensed by local afferents could drive BAT thermogenesis (diagram of procedure, Fig. 
12a). CL (0.2 ng/kg) or saline vehicle, was injected intra-right ventral IWAT exactly as 
above at three loci (5 µl/locus for a total of 15 µl). This dose was chosen based on 
neurophysiological recordings demonstrating dose-dependent IWAT afferent activation, 
Western blot data confirming increased lipolysis by significant pHSL/HSL increases of 
the pad delivered, and previous studies that determined CL microinjections of 0.2 ng/kg 
into IBAT did not affect core body temperature (Ryu et al., 2015). The incision was 
immediately covered with a warm saline-soaked gauze pad, animals were then moved to 
a circulating water warming pad set to 37 ° C and remained there under heat lamp with 
ambient air surrounding the animals stable at ~35-36 ° C. Temperature recordings from 
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IBAT were started immediately after the animal reached the warming pad then 
monitored every 5 min for 1 h postinjection as done previously (Ryu et al., 2015a). Core 
body temperature in these anesthetized animals was measured using a rectal 
temperature sensor connected to BAT-10 Thermometer (Physitemp Instruments). 
3.3.7 Data analysis 
3.3.7.1 Neurophysiological recordings 
The numbers of WAT afferent action potentials occurring as a function of time 
were integrated into either 30 sec bins and compared across treatments for unilateral 
recordings, or 10 min bins for bilateral recordings, where the onset of infusion up to 20 
min post infusion were compared against the pre-infusion 10 min baseline recordings. 
Percent change mean nerve activity from contralateral (vehicle-infused) IWAT was 
compared using one-way ANOVA for each treatment from baseline nerve activity. Nerve 
activity at individual time points across experiments were compared using Student’s t 
tests with Bonferroni correction via SigmaPlot (v12.3; Systat Software Inc., San Jose, 
CA). Results were considered significant if mean nerve activity in unilateral recordings—
or percent change from baseline activity in bilateral recordings—differed from vehicle 
control, p < 0.05. 
3.3.7.2 Western blot protein analysis 
Band intensity was quantified based on optical densitometry measurements 
using ImageJ (US National Institutes of Health, Bethesda, MA). The values for 
HSL/actin, and pHSL/actin were collected and ratios of pHSL/HSL were compared 
using paired samples t-tests between ipsilateral and contralateral IWAT within animals 
via SigmaPlot (v12.3; Systat Software Inc., San Jose, CA). Data are displayed (Fig. 9) as 
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arithmetic change in pHSL/HSL for clarity of presentation. Results were considered 
significant if mean pHSL/HSL from CL-infused pads differed from their contralateral 
vehicle-infused control, p < 0.05. 
3.3.7.3 c-Fos-ir and FB colocalization 
All labeled cells from three central sections of each DRG were counted from 
captured images by experimenters blind to treatment conditions. Raw totals for each 
label (e.g., c-Fos and FB) as well as c-Fos+FB colocalized cells were compared between 
drug treatments using multiple Mann-Whitney U tests at each ganglionic level. In 
addition, the percentage of FB labeled cells expressing c-Fos was compared between 
drug treatments at each ganglionic level and combined across all ganglia to demonstrate 
the specificity of CL infusion to individual IWAT afferent neurons. Comparisons were 
considered statistically different when DRG labeling ipsilateral to CL infusion differed 
from the contralateral vehicle-infused counterpart, p < 0.05. 
3.3.7.4 BAT and rectal temperature recordings 
Temperature and change in temperature from the “0 min” time point were each 
analyzed by repeated measures two-way ANOVA by drug treatment and the state of 
IWAT neural connectivity. Preplanned comparisons between treatments at each time 
point were conducted using multiple Student’s t test with Bonferroni correction. 
Comparisons were considered statistically different when temperature or change in 
temperature from baseline differed from animals whose IWAT was injected with saline 
and innervating nerves intact, p < 0.05. 
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3.4 Results 
2DG significantly increased neurophysiological activity of IWAT afferents in both 
0-5 min and 5-10 min post-stimulus time intervals (Student’s t test with Bonferroni 
correction; n = 13; baseline,  p = 0.143; pretreatment,  p = 0.448; 0-5 min, p = 0.050 ; 5-
10 min, p = 0.009, Fig. 7), and the 2DG-induced increase was blocked by pretreatment 
with propranolol relative to saline infusions.  
IWAT administration of the high dose of CL (0.2 ng/kg, Fig. 8b, c) also 
significantly increased neurophysiological spike activity beginning 5-10 min after the CL 
infusion, and lasting until the end of the recording session. IWAT neurophysiological 
spike activity was not increased in vehicle-injected contralateral IWAT or when CL was 
infused at a dose insufficient to induce lipolysis (0.1 ng/kg, Fig. 8b, c, Fig. 9). DMP 
blocked the ability of  a high dose of CL to stimulate WAT afferents , and interestingly 
inhibited their activity from 10-20 min post-infusion (repeated measures ANOVA; CL 
0.2 ng/kg, n = 7, p = 0.002; CL 0.1 ng/kg, n = 4, p = 0.964; CL 0.2 ng/kg + 12 mg/kg 
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Figure 7.  Glucoprivation increases IWAT multiunit nerve spiking in a β-AR dependent fashion. 
2DG (500 mg/kg, i.p.) increased IWAT multiunit spiking, an effect blocked by pretreatment with β-AR antagonist 
propranolol. Bars represent number of spikes per 30 sec of IWAT afferents in hamsters that received either 
propranolol (40 mg/kg, s.c.) or saline vehicle (s.c.) pretreatment prior to 2DG application. * p < 0.05. 
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DMP, n = 5, p = 0.158; Student’s t test with Bonferroni correction; CL 0.2 ng/kg, n = 7, 
0-10 min, p = 0.022, 10-20 min, p = 0.002; CL 0.1 ng/kg, n = 4, 0-10 min, p = 0.779, 10-
20 min, p = 0.968; CL 0.2 ng/kg + 12 mg/kg DMP, n = 5, 0-10 min, p = 0.979, 10-20 
min, p < 0.001).  
CL-induced lipolysis was confirmed by examining the change in ratios between 
pHSL and HSL using Western blot as a well-established marker for fat-pad-specific 
sympathetically dependent lipolysis (Bartness et al., 2014a; Buettner et al., 2008). CL 
infusion (0.2 ng/kg) increased pHSL:HSL after 15 min but did not affect pHSL:HSL 
Figure 8. Intra-adipose β3-AR agonism increases IWAT multiunit nerve activity. 
(a) Diagrammatic representation of real-time in vivo bilateral multiunit electrophysiology of WAT afferent nerves. 
Afferent nerves resected from ventrally exposed IWAT (blue curved lines), cut proximal to electrodes (gray hook 
pairs) to eliminate efferent interference, and analyzed for multiunit spike frequency over time. Symmetrically placed 
infusion needles indicate bilateral simultaneous infusion of lipolytic drug CL316,243 (CL, β3-AR agonist) and its 
sterile saline vehicle (no drug) in the contralateral negative control pad. (b) CL dose-dependently increased IWAT 
multiunit spiking, an effect blocked by pretreatment with the antilipolytic drug 3,5-dimethylpyrazole (DMP, 12 
mg/kg, i.p). Data are expressed as a percentage change of activity from CL-infused pad over contralateral to eliminate 
whole animal IWAT nerve variability caused by the recording/injection procedure. Inset is a representative single 
spike to display acquired waveforms. (c) Representative (20 sec) traces from IWAT afferents and contralateral 
counterparts at baseline and 20 min post-infusion where the ipsilateral IWAT was infused with CL at either 0.2 ng/kg 
(top), 0.1 ng/kg (middle), or 0.2 ng/kg 20 min after pretreatment with antilipolytic drug DMP (bottom). Scale bars on 
first trace apply to all traces. Dotted line separates ipsilateral vs contralateral IWAT afferent recordings from each of 
the three representative animals. * p < 0.05. 
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when animals had been pretreated with DMP (12 mg/kg, CL 0.2 ng/kg) or CL only at a 
lower dose (0.1 ng/kg, Fig. 9) (paired t tests; CL 0.2 ng/kg, n = 17, p = 0.015; CL 0.1 
ng/kg, n = 5, p = 0.193; CL 0.2 ng/kg + 12 mg/kg DMP, n = 5, p = 0.515). ATGL did not 
differ among treatment groups (p > 0.05).  
FB neurotracing and c-Fos colocalization revealed a specific activation of DRG 
neurons connected directly to IWAT on the side ipsilateral to the high dose of CL 
infusion (0.2 ng/kg, Fig. 10a-f, j) despite nearly identical neurotracer labeling (Fig. 10h) 
and only a trend toward higher overall c-Fos-ir (Fig. 10i) (Mann-Whitney Rank Sum 
Tests; FB, T12, n = 7, p = 0.905; T13, n = 7, p = 0.571; L1, n = 7, p = 0.556; L2, n = 7, p = 
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Figure 9. Intra-adipose CL increases pHSL/HSL indicating β3-AR induced lipolysis. 
(a-b) Western blot analysis of the ratio of pHSL to HSL and ATGL reveals increased stimulated lipolysis with 0.2 
ng/kg but not 0.1 ng/kg CL 15 min after infusion. In addition, pretreatment with DMP (i.p.) blocked CL stimulatory 
effects. Colored bars indicate (a) the mean ratio of pHSL to HSL and (b) ATGL in CL-injected IWAT compared with 
their saline-injected contralateral control IWAT (white bar). Error bars indicate SEM. Representative blots are 
provided as the inset with the label color and order of the bars used to indicate treatment (all units in ng/kg). * 
different from contralateral saline injected pad, p < 0.05. 
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0.486; L3, n = 7, p = 0.286; c-Fos-ir, T12, n = 7, p = 0.556; T13, n = 7, p = 0.250; L1, n = 
7, p = 0.111; L2, n = 7, p = 0.686; L3, n = 7, p = 0.905; Colocalized, T12, n = 7, p = 0.190; 
T13, n = 7, p = 0.502; L1, n = 7, p = 0.032; L2, n = 7, p = 0.030; L3, n = 7, p = 0.041). In 
addition, the percent of FB labeled cells expressing c-Fos tended to increase in L3 but 
was significantly higher at ganglionic levels L1, L2, and overall across T12-L3 (Mann-
Whitney Rank Sum Tests, T12, n = 7, p = 0.215; T13, n = 7, p = 0.442; L1, n = 7, p = 
0.032; L2, n = 7, p = 0.029; L3, n = 7, p = 0.063; Total, n = 35,  p = 0.001).  
EPA, AA, and a cocktail of both together each significantly increased 
neurophysiological activity of IWAT afferent nerves (Fig. 11a, b) (repeated measures 
ANOVA; EPA, n = 6, p = 0.013; AA, n = 3, p = 0.003; EPA+AA cocktail, n = 4, p = 
0.005). Post hoc analysis revealed lipolytic products EPA and AA each increased 
multiunit activity to a similar magnitude and latency of effect as the high dose of CL. 
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Figure 10. Intra-adipose β3-AR agonism increases c-Fos-ir in DRG neurons connected to IWAT. 
(a-f) Representative images of Fast Blue (FB, a, d) positive, c-Fos (b, e)-ir, and colocalized (c, f) neurons in DRG at the 
L2 vertebral level from the same animal both contralateral (top) and ipsilateral (bottom) to CL injections. Scale bar = 
100 µm. White arrows indicate some but not all labeled cells of interest and rows are separated by treatment. (g-i) 
Neuronal number counted from three central-most sections of each DRG, each animal, and both treatments positive 
for FB (g), c-Fos-ir (h), or both (i). (j) Percentage of FB labeled neurons expressing c-Fos at each vertebral level (T12-
L3) from animals injected with CL into their ipsilateral IWAT and saline vehicle into their contralateral IWAT. * p < 
0.05, ** p < 0.001. 
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(Student’s t test with Bonferroni correction; 0-10 min:  EPA, n = 6, p = 0.047; AA, n = 3, 
p = 0.019; 10-20 min:  EPA, n = 6, p = 0.015; AA, n = 3, p = 0.003).   
IBAT temperature change from baseline was significantly increased after CL 
infusion in WAT pads with intact neural innervation (repeated measures ANOVA; n = 
36, p < 0.001) as early as 5 min post infusion and persisted for every time point 
measured (Fig. 12c). This effect was abolished when WAT was denervated before CL 
infusion and did not increase when saline was infused into denervated WAT (Fig. 12c). 
Anesthetized hamsters experienced mild post anesthesia-induced hypothermia (Shimizu 
& Saito, 1991) after which IBAT (repeated measures ANOVA; n = 36, p < 0.001) and 
rectal raw temperatures (repeated measures ANOVA; n = 36, p < 0.001) slowly 
increased over time throughout the experiment (Fig. 12b, d); however, neither IBAT 
(repeated measures ANOVAs; n = 36, p < 0.183) nor rectal (repeated measures ANOVA; 
Figure 11. Intra-IWAT eicosopentanoic acid (EPA) and arachidonic acid (AA) increases IWAT 
multiunit nerve activity. 
(a) EPA, AA, and a mixture of EPA + AA all increased IWAT multiunit spiking with a similar magnitude and latency 
to effect. Data are expressed as a percentage change of activity from baseline nerve activity. (b) Representative (8 sec) 
traces from IWAT afferents and contralateral counterparts at baseline and 20 min post-infusion. Scale bars on first 
trace apply to all traces. Dotted line separates ipsilateral vs contralateral IWAT afferent recordings from each of the 
three representative animals. * p < 0.05. 
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n = 36, p = 0.922) raw temperatures differed among treatment groups at baseline or any 
subsequent time point measured (Fig. 12b, d).  
3.5 Discussion 
IWAT afferents are activated by 2DG-induced glucoprivation (Song et al., 2009) 
and the present results show that this effect is attenuated by propranolol pretreatment, 
suggesting that β-AR-dependent lipolysis drives IWAT afferent spiking (Fig 8b, c). 
IWAT afferent activation appears to be reliant on local CL-induced lipolysis, as 
evidenced by increases in:  1) WAT HSL phosphorylation, 2) neurophysiological spike 
activity of WAT afferents, and 3) c-Fos immunoreactivity in adipose tissue-connected 
Figure 12. CL-induced IWAT afferent stimulation is sufficient to increase BAT thermogenesis. 
(a) Diagrammatic representation of the experimental setup. IWAT was either denervated or nerves left intact then 
injected with saline or a dose of CL 316,243 (0.2ng/kg) shown to increase IWAT afferent activity. (b) BAT 
temperature, (c) change in BAT temperature from baseline and (d) rectal temperature over the 60 minute recording 
period all demonstrate WAT afferent activation specifically increases BAT thermogenesis, * p < 0.05. 
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sensory spinal neurons in the DRG. Furthermore, blocking CL-induced lipolysis with 
DMP pretreatment attenuated WAT CL-induced HSL phosphorylation (Fig. 9a) and 
blocked IWAT afferent activation (Fig.  8b, c). Although we did not observe increases in 
WAT ATGL protein content 15 min after CL injections, pHSL was significantly higher 
(Fig. 9a, b) demonstrating enhanced β3AR stimulation as a proxy for WAT lipolysis. To 
further support the hypothesis that lipolysis activates WAT afferents, we then tested two 
fatty acids known to be highly released during norepinephrine-induced lipid 
mobilization (Raclot & Groscolas, 1993) and both EPA and AA were sufficient to drive 
WAT afferent neurophysiological activity in the absence of CL. These data together 
suggest that lipolysis products are sufficient to drive WAT afferent spiking, perhaps 
relaying the amount and types of released lipid to the CNS.  
Sensory nerves identified within adipose tissue—using immunohistochemistry 
for CGRP and substance P as a afferent nerve markers—are predominantly located 
around major blood vessels and less commonly innervate the parenchymal adipose 
depot (De et al., 1998). This observation is further illustrated by electron micrographs of 
the adipose cellular architecture (Cinti, 1999; Giordano et al., 1996). It is unlikely then 
that WAT afferents activated by CL infusions circumvent adipocytes at their cellular 
borders and most immediate site of efflux, but rather might serve as lipid sensors from 
WAT at the entry point to the bloodstream. The possible role of WAT afferent lipid 
sensors around major blood vessels may be to inform the CNS about the quantity and 
types of lipid species entering circulation. Furthermore, the functional association 
between WAT afferents and SNS outflow may exist to sense and potentially regulate 
released lipid and/or adipokines from individual fat depots to the rest of the body. 
Because of the variety of signals sensed, and potential for WAT to control SNS outflow 
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to other tissues, perhaps the primary role of WAT afferents is to distinguish these WAT 
depot-specific contributions to the bloodstream from lipid and adipokines accumulated 
in the bloodstream from other WAT depots and elsewhere.  
To help understand the physiological context of this newfound sensory signal, we 
tested for the existence of a functional WAT to BAT neural link and for the first time 
demonstrate acute sufficiency of the neural connectivity from WAT to BAT to drive BAT 
thermogenesis (Fig. 12a-d). The general connectivity between WAT afferents and BAT is 
not novel to these present experiments because others have measured diminished BAT 
thermogenic capacity (Giordano et al., 1998) and atrophy of the BAT after the 
destruction of afferents by sensory excitotoxic denervation (Cui & Himms-Hagen, 
1992b; Cui et al., 1990). Albeit chronic and loss of function methods to test the necessity 
of WAT afferents for healthy BAT function, these afferent lesion studies demonstrate 
that our findings are not solitary but together reiterate the likely neural interaction from 
WAT to BAT. Because surgical denervation blocked BAT temperatures in CL-infused 
WAT (Fig. 12a-d), this WAT to BAT neural circuitry likely induces BAT thermogenesis 
by either causing the adrenal release of norepinephrine or more likely the increase of 
efferent neural activity to BAT directly (Bartness & Ryu, 2015). Despite the anatomical 
pathway by which WAT CL infusion triggers BAT thermogenesis, we have measured an 
acute and robust thermogenic response by BAT—in line with other evidence—as a novel 
SNS output of the adipose afferent reflex (AAR) supported by others (Xiong et al., 2014).  
Earlier reports by us and others (Murphy et al., 2013; Niijima, 1998) suggest 
WAT afferents activated by leptin presumably relay an inventory signal to the brain but 
also increase blood pressure via the AAR (Xiong et al., 2014), whereas we now provide 
evidence that WAT afferents are activated by the local release of lipid and are sufficient 
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to increase BAT temperature. Taken together, these reports identify heterogeneity 
among WAT afferents. It is still unclear, however, whether single WAT afferent neurons 
are receptive to both leptin and lipids or perhaps there are distinct neurons that sense 
and generate these seemingly different reflexive outputs. Additionally, peripheral 
afferent nerves also presumably release CGRP into their innervating tissue to which it is 
unclear how decentralizing afferent fibers in this study have affected subsequent 
afferent activity or adipose sensitivities to CL. Interestingly, CGRP injected directly into 
BAT attenuates norepinephrine-induced thermogenesis and is innately released by BAT 
afferent activation. This suggests that afferents possibly regulate adipose function via 
negative feedback (Osaka et al., 1998). Despite these effects in BAT, we believe that our 
within-animal design employed during neurophysiological recordings mitigates the 
confounding effects of WAT afferent neuropeptide release in this study. Clearly, further 
and more refined investigation is needed to interrogate WAT afferent functions to 
potentially discover bidirectionally active labeled-lines of opposing or parallel metabolic 
functions. The existence of apparently distinct AAR outputs suggests that lipolysis-
activated WAT afferents also increase blood pressure and thereby facilitate newly 
released lipid distribution throughout the body, to fuel BAT thermogenesis. Such a 
system may allow us to better understand mechanisms of SNS dysregulation in human 
obesity (i.e., wherein SNS is overactive and stimulated-lipolysis is high) (Bartness et al., 
2014a). 
Altogether, these results provide evidence that WAT afferents—shown by us and 
others to be involved in 1) SNS feedback regulation to multiple tissues (Niijima, 1998, 
1999), 2) SNS-induced hypertension (Xiong et al., 2014), 3) neural SNS feedback loops 
that are sensitive to insulin (Ding et al., 2015c), 4) regulation of fat deposition 
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throughout the body (Shi & Bartness, 2005), and 5) food intake regulation (Yamada et 
al., 2006)—increase their activity in response to the basic biological process of 
stimulated lipolysis (i.e., simulated SNS outflow). In addition, one function of these 
lipolysis-activated WAT afferents is to increase BAT temperature in an acute fashion: a 
circuit which perhaps exists to correctly time the release of FFAs from WAT with the 
engagement of thermogenic machinery in BAT. This novel sensory signal has 
implications for many past and present studies examining the neural control of energy 
balance during physiological challenges where SNS-induced lipolysis is high (e.g., food 
deprivation, cold exposure, and glucoprivation) (Dunn & Adams, 2014); therefore, we 
must continue to consider this synchrony of organ systems to more wholly understand 
homeostatic mechanisms of survival during energy challenges. 
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4.1 Introduction 
WAT afferent functions have been examined by two primary approaches: 1) Loss 
of function experiments using surgical denervation (which also removes efferent output 
to WAT) or excitotoxic chemical denervation using high dose capsaicin (Jancso et al., 
1984) or resinerfertoxin (Acs et al., 1997) surgically injected into WAT of anesthetized 
rodents. Results of these experiments establish the necessity of chronic WAT afferent 
activity but the approaches employed have two shortcomings: the former completely 
removes afferent but also efferent SNS projections into WAT, while the latter is afferent 
specific but not complete, as it only targets capsaicin sensitive fibers and is believed to 
decrease sensory innervation by only approximately 40-50%. Each type relies on a 
surgical recovery period before function can be measured wherein nerve regrowth and 
compensatory mechanisms that compensate for afferent nerve destruction may occur. 
The second approach 2) is extracellular neurophysiological recordings in anesthetized 
animals beginning with Niijima’s (1998) discovery that leptin activates WAT afferents 
(Niijima, 1999) and used more recently with understanding mechanisms of the AAR 
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(Shi et al., 2012; Xiong et al., 2012; Xiong et al., 2014). These methods—similar to that 
described in chapters 2 and 3 above—are used to identify WAT afferent sensation. 
Although valuable, this second approach cannot well characterize the role of WAT 
afferents in metabolic and behavioral responses of awake behaving animals. It is clear 
that a novel approach capable of testing real-time physiological consequences of WAT 
afferent activity is needed, which would markedly impact the field of integrative 
physiology.  
In order to target WAT afferents specifically, we explored transgenic mouse 
models that employ afferent nerve specific promotors. Advillin—transcribed by the 
AVIL gene—is expressed only within neurons and is important for ganglionic 
development; moreover, advillin expression is primarily peripheral and entirely limited 
to afferent but not efferent neurons (Zurborg et al., 2011). Our collaborator (Y.B.S., 
NIH) has supplied mice (AVILcre+) wherein cre-recombinase is coexpressed with AVIL 
on afferent but not efferent peripheral neurons (Fig. 13 from (Zurborg et al., 2011)). 
These mice are viable and exhibit no metabolic deficits or observable phenotypic 
differences compared with wild-type mice. As such, the AVILcre+ mice are ideal tools for 
cre-dependent strategies of adipose afferent control.  
Figure 13. AVILcre+ expression in mouse (modified from Zurborg et al.,2011). 
X-gal staining in whole-mount spinal DRG from adult mice. Cre mediated recombination was detected in adult 
AVILcre+. Figure from (Zurborg et al., 2011). 
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This AVILcre+ combinational transgenic mouse model permits conditional genetic 
modifications in adulthood for the first time. Cre-dependent adeno-associated viral 
vectors (AAVs) that insert activation/inactivation receptors (e.g. Designer Receptors 
Explicitly Activated by Designer Drugs [DREADDs]) can be utilized to test WAT afferent 
control of energy balance and feeding behavior. Thus, we have designed a strategy to 
infect WAT afferents with cre-dependent AAVs carrying DREADDs (Gq [excite WAT 
afferents], or Gi [inhibit WAT afferents]) (Krashes, Shah, Koda, & Lowell, 2013), using 
this AVILcre+ model for a novel, highly specific, and reversible chemogenetic control of 
WAT afferents in vivo. Using this approach, we will measure behavioral and metabolic 
consequences of WAT afferent activation/inhibition to test the effects of WAT afferent 
activity on energy balance and feeding behavior.  
4.2 Method and Results  
This section is organized chronologically to best represent the logical 
improvements to study design as new developments unfold during the assessment of 
this unique chemogenetic approach of WAT afferent nerve control. As this work is in a 
preliminary stage, the developing methodology and results in the following three 
sections (i.e. Pilot, Experiment 1, Experiment 2) are outlined in general form.  
4.2.1 Pilot experiment using AAV2 transduction of excitatory 
DREADDs 
AVILcre+ (n=2) mice and a wild type mouse were anesthetized and then surgically 
injected with AAV2-hSyn-DIO-hM3D(q)-mCherry (10 x 1 µl injections totaling 2.0 x 1010 
viral particles per loci) into IWAT to drive expression of excitatory (hM3D[q]) receptors 
in IWAT afferent nerves. This viral construct and ones used in future experiments were 
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all produced by Bryan Roth (Krashes et al., 2011) and deposited into the University of 
North Carolina Viral Vector Core for commercially available distribution. This family of 
viral constructs are packaged into a variety of AAV serotypes and designed for cre-
dependent translation of DREADD-mCherry fusion proteins by cells that express the 
neuronal-specific synapsin promotor (hSyn). Furthermore, DREADDs-mCherry fusion 
translation is cre-dependent due to the double-floxed inverted open reading frame 
(DIO) flanking the target sequence. Thus, AAV2-hSyn-DIO-hM3D(q)-mCherry injected 
into IWAT of AVILcre+ should cause hM3D(q)-mCherry (excitatory DREADD) 
translation in cre-recombinase positive AVIL neurons (i.e. IWAT afferents). Two weeks 
after AAV infection, mice were food deprived for 12 hr then WAT afferent nerves were 
activated with clozapine-N-oxide (CNO, 0.5mg/kg i.p., DREADD agonist). Food 
deprivation-induced food intake was measured at 1 and 2 hr after refeeding. Mice were 
sacrificed by sodium pentabarbitol overdose, transcardially perfused, and DRGs (T12-
L3) extracted for histological verification of mCherry in Fast Blue labeled neurons.  
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4.2.1.1 Pilot experiment: Results 
This initial examination revealed a measurable attenuation of food deprivation-
induced refeeding (Fig. 14a) as well as likely infection of adipose afferents evidenced by 
mCherry visualization on Fast Blue labeled neurons from IWAT (Fig. 14b). Given these, 
data, sample sizes were increased for future experiments and to more thoroughly 
characterize the effects of WAT afferent nerve activity on metabolism.    
IWAT afferents attenuate 
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Figure 14. Pilot experiment demonstrating probable DREADD control of IWAT afferents. 
Food intake of AVILcre+ transgenic (Tg, n=2) and one wild type littermate. Mice were food deprived for 12 hours and 
administered CNO upon refeeding. B) DRG (T13) hm3D(q)-mCherry visualization on AVILcre+ mouse injected with 
AAV2/hSyn-DIO-hm3D(q)-mCherry dissolved in fast blue neurotracer (pseudocolored green). Animals were 
sacrificed then perfused 3 weeks after infection into bilateral IWAT. 
 
83 
4.2.2 Experiment 1: Chemogenetic control of WAT afferents 2 weeks 
after AAV2 injection into IWAT. 
Using a similar approach to pilot experiments with the addition of a new group of 
mice injected with AAV2-hSyn-DIO-hM4D(i)-mCherry (inhibitory DREADD), we 
submitted all mice (n=16) to our experimental model (Fig. 15). AVILcre+ and wild type 
mice were injected with AAVs, and were then analyzed two weeks later for baseline body 
mass, fat mass, and lean mass using time-domain nuclear magnetic resonance 
technology (TD-NMR) by a MiniSpec machine (Bruker; Spring, TX). Mice were then 
assigned to individual TSE PhenoMaster metabolic chamber cages (TSE Systems; 
Chesterfield, MO) where energy expenditure, respiratory exchange ratio (RER), food 
intake, and locomotor activity were measured. After 3 days of acclimation, cages were 
cleaned and fresh bedding was given. All mice were given 0.5 mg/kg CNO twice daily for 
the remaining 4 days in metabolic chambers. On Day 1 and Day 2 after acclimation, 
mice were fed ad libitum, followed by a 24 hr food deprivation, then refed with 
continuous measurements for the remaining 16 hr (Fig. 15). After 7 days, all mice were 
removed from metabolic chambers, reanalyzed for their body composition, and then 
returned to their home cages. One week later, all mice were euthanized for histological 
verification of viral transfection.  
Figure 15. Timeline for metabolic chamber experiments using AAV2 transfection of DREADDs. 
Metabolic chamber characterization of ad libitum fed mice given twice daily CNO for 3 days. 
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4.2.2.1  Experiment 1: Results 
Unlike the pilot data acquired at the onset of this study, we observed no or trivial 
differences among treatment groups across all measures (Figs. 16, 17). In addition, 
confounding food intake differences between AVILcre+ and wild type mice were present 
Figure 16. Experiment 1: Metabolic consequences of hm3d(q) activation of IWAT afferent nerves.  
Food intake was significantly lower in AVILcre+ mice before and after CNO was administered. *p < .05, **p < 0.01. 
Figure 17. Experiment 1: hm4d(i) inhibition of IWAT afferent nerves does not produce a robust 
phenotype.  
Energy expenditure was significantly lower in AVILcre+ mice before and after CNO was administered. *p < .05, **p < 
0.01. 
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during acclimation before CNO was administered (Fig. 16c). No differences in energy 
expenditure were detected on days where CNO was administered. Of note, the only 
difference in energy expenditure was between hm4D(i) AVILcre+ and wild type mice 
during acclimation before any exposure to CNO (Fig. 17a).  Postmortem assessment of 
AAV2 transduction of mCherry revealed that previous pilot characterization of 
endogenous mCherry (viral-mediated mCherry fluorescence) may have been nonspecific 
fluorescence apparent also in wild type mice (Fig. 18, top). We were able to confirm 
transduction of mCherry only after IHC in fixed DRG sections. Robust and specific 
mCherry fluorescence was observed in AVILcre+ mouse neurons, suggesting that AAV2-
Figure 18. AAV2 translation of mCherry and c-Fos response to CNO. 
Top) mCherry fluorescence without IHC amplification in wild type (left) and AVILcre+ mice (right). Middle) IHC 
amplification of mCherry with Alexa 488 (green). Bottom) c-fos immunoreactivity 60 min after CNO 0.5mg/kg.  
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hSyn-DIO viruses successfully infect and sufficiently transduce mCherry-hm3D and 
mCherry-hm4D expression (Fig. 18, middle).  
Due to 1) the ambiguous endogenous mCherry fluorescence in DRGs, 2) 
equivalent CNO-induced c-fos between groups (Fig. 18, bottom), 3) underwhelming 
phenotype from what theoretically should be a vigorous and chronic activation of IWAT 
afferents, and 4) differences between the pilot data and data acquired in this 
experiment, we conclude that DREADD control of these nerves was not effectively 
accomplished. In Experiment 2, we define particular strategies we used to enhance the 
likelihood of AAV transfection, effective measurement, and assessment of this WAT 
afferent nerve chemogenetic approach.  
4.2.3 Experiment 2: Chemogenetic control of WAT afferents 6 weeks 
after AAV8 injection into IWAT and GWAT.  
Viral trafficking efficiency of AAVs is not contiguous among the variety of 
serotypes (Castle, Gershenson, Giles, Holzbaur, & Wolfe, 2014). Correspondence with L. 
Vulchanova (Schuster et al., 2014; Schuster et al., 2013) and examination of the 
retrograde/trafficking efficiency of various serotypes discriminates against the use of 
AAV2 as a highly efficient virus for viral uptake/trafficking from neural process, but 
rather suggests AAV8 and AAV9 as more robust alternatives. Commercial availability of 
AAV8-hSyn-DIO-hm3/4D (UNC Vector Core; Chapel Hill, NC) allows efficient access to 
a more robust transduction agent to target sensory terminals. The enhanced efficiency 
of AAV8 compared with AAV2 likely will improve the efficiency of mCherry-DREADD 
translation by WAT afferents and thus their activity induced by CNO (Zheng et al., 
2010). Although AAV8 is less efficient for retrograde transport than is AAV9 (Schuster 
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et al., 2014), its cost and immediate availability makes it preferred over AAV2 in order to 
improve endogenous mCherry expression and likely DREADD translation. Also in an 
effort to improve AAV8-induced translation of mCherry and DREADDs, we increased 
the duration of time after infection from two weeks to six.  
Activation of adipose afferents only from IWAT may be insufficient to drive a 
reproducible behavioral and/or physiological phenotype. Considering this possibility, 
we also infected bilateral GWAT to control adipose afferents from four total fat pads 
simultaneously. We believe that if any effect is to be achieved by adipose afferent 
control, increasing the number of infected adipose afferent neurons may improve the 
likelihood of producing a discernable phenotype. Because both GWAT and IWAT 
afferents are leptin sensitive (Murphy et al., 2013; Shi et al., 2012), produce similar SNS 
increases in anesthetized rats, and connect with similar level DRGs (T12-L3), it is likely 
that that GWAT and IWAT afferent activation together produces a stronger cohesive 
effect rather than two conflicting/counteracting effects.  
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CNO is used throughout the literature in the context of hm3D(q) stimulation at 
doses ranging from 0.3 mg/kg (Krashes et al., 2011) to 3.0 mg/kg (Nicoleau, Nation, 
Kinsman, Browning, & Stocker, 2016). The dose of 0.5 mg/kg was in the pilot study and 
Experiment 1, it is unclear if this dose is sufficient to induce WAT afferent nerve control 
given this unique strategy using peripheral DREADDs. Thus, we have increased the 
CNO dose to 3.0 mg/kg as this has still been shown to be inert in wild type mice 
metabolism and imbues greater confidence that DREADDs will be stimulated even after 
low viral efficiency. Importantly, there is little evidence to suggest sensitization of 
Figure 19. Timeline for Experiment 2a-f using AAV8 DREADD 6wks after infection. 
Experiment 2a-f in chronological order. The same AVILcre+ and wild type mice were subjected to four experiments (a-d) 
between 6-10 weeks after viral infection then sacrificed at the end of BAT/core temperature measurements. a) Food 
deprivation-induced refeeding experiment conducted by manual food weight measurement 1, 2, 4 hr up to 6 days after 
CNO+refeeding. b) Metabolic chamber characterization of ad libitum fed mice given daily CNO for 3 days. c) Blood 
glucose measurements in response to CNO. d) BAT and body temperature in response to CNO of anesthetized mice. e-f) 
postmortem assessment of mCherry expression and neuronal activity of dissociated cultured DRG neurons (e) and fixed 
DRG histological sections (f).  
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animals to CNO based on high and/or multiple doses (Roman, Derkach, & Palmiter, 
2016).  
Automated metabolic chamber food intake measurements do not account for 
food spillage (i.e. food removed from automated hoppers that remains in soiled bedding 
and not eaten) and could explain differences in measured food intake between the pilot 
and Experiment 1. Therefore, we first food deprived animals for 12 hr then manually 
weighed food 1, 2, 4, 24 hr, and each day for 6 days after refeeding. This was performed 
to best mimic the pilot experimental design. In addition to these measures and the use 
of metabolic chambers in Experiment 1, additional experiments were added in 
Experiment 2 to test the role of WAT afferent activity on blood glucose and BAT 
thermogenesis (Fig. 19c-f). These experiments were added to investigate known effects 
of WAT afferent activity on other systems (Ding et al., 2015b; Niijima, 1998). 
Figure 20. Experiment 2a: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not 
produce a food intake differences after food deprivation. 
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4.2.3.1 Experiment 2 results 
Unlike the pilot data acquired at the onset of this study, we observed no or trivial 
differences among treatment groups in food deprivation-induced feeding (Figs. 19a, 20) 
or food intake and energy expenditure measures within metabolic chambers (Fig. 19b, 
21). This was clear in all time points measured after food deprivation-induced refeeding 
(Fig. 19a, 20), but less clear in wild type and AVILcre+ mice housed in metabolic cages 
Figure 21. Experiment 2b: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not 
produce robust differences in metabolic measures. 
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(Fig. 21a, b). Similar to Experiment 1, AVILcre+ mice infected with AAV8-hm3D had 
different baseline food intake (Fig. 16c) during metabolic chamber acclimation before 
CNO was given compared with wild type mice (Fig. 21a, inset). Unlike Experiment 1, 
Experiment 2b AVILcre+ ate more than wild type mice (Figs. 16a, 21a). This result could 
be due to the previous exposure to CNO which was given eight days prior in Experiment 
2a (see timeline Fig. 19). Accordingly, CNO could be causing delayed or chronic feeding 
effects beginning with injections during Experiment 2a and continuing to affect baseline 
differences in feeding during Experiment 2b (Fig. 21b) conducted on the following week. 
However, the difference between AVILcre+ mice in Experiment 1 and AVILcre+ mice in 
Experiment 2b is unclear, but may be driven by higher food spillage of AVILcre+ mice in 
Experiment 2b (data not shown). CNO treatment increased locomotor activity (Fig. 21c) 
but did not affect energy expenditure. Body composition at any time points measured 
was not different between treatment groups (data not shown). Metabolic chamber data 
Figure 22. Experiment 2d: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not 
produce a differences in BAT or body temperature. 
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for AAV8 hm4D(i) injected AVILcre+ and wild type mice were corrupted by non-stable 
reference CO2 measurements and thus are inconclusive (data not shown).    
Neither BAT temperature (Fig. 22) nor blood glucose (Fig. 23) was affected by 
CNO injection in AVILcre+ or wild type mice. Reminiscent of baseline food intake 
differences in Experiment 2b, BAT temperature was higher in AVILcre+ mice at baseline. 
Much like the above possibility, this baseline difference could be due to the prior 
administration of CNO from Experiments 2a-c (Fig. 19).  
Figure 23. Experiment 2c: AAV8-hm3d(q) activation or AAV8-hm4d(i) inhibition of IWAT and GWAT 
afferent nerves does not produce a differences in blood glucose. 
Figure 24. Experiment 2e: CNO applied to dissociated mCherry-positive DRG neurons from AVILcre+ 
mice increases intracellular calcium. 
93 
Postmortem analysis revealed mCherry positive cultured DRG neurons from 
AVILcre+ mice infected with AAV8-hm3D(q); furthermore, we identified intracellular 
calcium increases after CNO bath application (Fig. 24). DRG neurons positive for 
mCherry increased intracellular calcium after CNO application suggesting excitatory 
DREADDs [hm3D(q)] were present and functional on WAT afferents infected with 
AAV8. Similarly, CNO application modestly decreased intracellular calcium of mCherry 
positive neurons with inhibitory DREADDs [hm4D(i)] (data not shown). These data 
collectively indicate that DREADDs can be inserted on WAT afferents, and that 
endogenous mCherry expression can be detected in dissociated DRG neurons without 
the use of antibodies. This finding constitutes the largest degree of success for our 
approach thus far. These positive control experiments establish that our method for 
DREADD insertion is robust and infects approximately 80% of the neurons observed 
Figure 25. Experiment 2e: CNO applied to dissociated mCherry-positive DRG neurons from wild type 
mice injected with hm3d(q) increases intracellular calcium. 
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(J.T.G., unpublished observations), a percentage of total DRG neurons homologous to 
H129 transneuronal labeling efficiency of IWAT afferents (Song et al., 2009).  
Unfortunately, we also have also accumulated evidence to suggest that either 
because of impure AAV8s obtained commercially, and due to the large volumes of total 
virus injected into each animal (~32 µl across all four WAT pads), mCherry expression 
and CNO-induced calcium changes are observed in both AVILcre+ and wild type mice. 
Indeed, DREADD expression using the viral construct delivered by AAV8 is non-
specific. Our negative control groups [wild type injected with AAV8-hSyn-DIO-
mCherry-hm3D(q)/hm4D(i)] robustly express mCherry in DRGs across all levels 
extracted T12-L3 and dissociated cultured neurons. Neurons from wild type injected 
with AAV8-hm3D(q) were activated by CNO application to the same magnitude and 
latency of AVILcre+ neurons (Fig. 25). The exact problem that led to these results is still 
under investigation but appears to be driven both by inconsistency in the viral 
constructs as well as high viral injection titres/volumes used in these studies.  
4.3 Discussion 
The surprising findings of non-specific DREADD insertion in Experiment 2 pose 
two major problems for our novel approach to control adipose afferent nerve activity. If 
AAV8s are causing mCherry-hm3D(q) expression in neurons that are negative for cre-
recombinase then 1) WAT afferents in our wild type negative control mice were 
activated to a similar degree as afferents in our AVILcre+ experimental mice, and 2) SNS 
neurons in all animals injected are presumably being infected and activated as well. 
These two problems limit our ability to draw conclusions from any of the experiments 
using viral constructs delivered by AAV8 (i.e. Experiments 2a-f, Fig 19).  
95 
It is possible that AAV2 infection specifically caused mCherry-DREADD 
translation within cre-recombinase positive neurons, yet a reliable phenotype was not 
achieved due to shortcomings discussed above from Experiment 1 to Experiment 2 (e.g. 
CNO dose, number of fat depots injected, time after infection, added experiments, see 
Fig. 19). Thus, methods involving AAV2-induced DREADD expression may be replicated 
in the future in addition to assessing the validity of AAV9 retrograde transport (Schuster 
et al., 2014).  Overall, refined control experiments must be conducted before meaningful 
conclusions can be reached as to the capacity of WAT afferents to affect physiology in 
vivo. 
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5 CONCLUSIONS AND FUTURE DIRECTIONS 
We have expanded the known sensitivities and capacities of adipose afferents by 
demonstrating their 1) within-BAT neural feedback circuits, 2) sensitivities to BAT 
thermogenesis, and 2) role as lipid sensors. We also have identified a functional neural 
link between WAT and BAT that drives thermogenesis. The novelty represented by this 
body of work lies within our particular strategy employed to test the effects of adipocyte-
derived signals on adipose afferents rather than their sensitivity to exogenously injected 
ligands [e.g. leptin (Niijima, 1998), capsaicin (Shi et al., 2012)]. In addition, our 
bilateral simultaneous neurophysiological recording technique demonstrates that WAT 
afferents are able to distinguish local signals from circulated factors. Together, these 
data highlight an emerging role of these sensory fibers in their sensitivities and potential 
to exert control of basic adipocytes functions. Future explorations of this system seek to 
discover unique strategies to treat obesity by the specific neural control of WAT and 
BAT functions.  
 Taken together, the similar potential of WAT and BAT afferents to sense SNS-
directed adipose activity reveals a novel signaling mechanism of energy depletion to the 
brain. Importantly, adipose afferents seem to be sensitive to many signals (e.g. leptin, 
adenosine, bradykinin, lipolysis, thermogesis) but the precise segregation of these 
signals has not been explored. Because of the multiunit approach to measuring adipose 
sensitivities, we and others can only describe macro activation of entire peripheral 
nerves that knowingly contain many individual firing units. Future explorations with 
enhanced neuronal precision need to disentangle these signals to test whether these 
activators increase spiking in individual parallel pathways integrated at their point of 
convergence or whether all adipose afferents are each activated by these excitatory 
97 
events and transduce the milieu of signals beginning at the tissue level. Possibly, the 
adipose afferents share similar organization to vagal afferent innervation whereby 
specific neurons send parallel messages (e.g. stomach stretch, nutrient intake) from the 
gut to the brain for central processing (Williams et al., 2016).  
 Although many studies—including ours above—demonstrate adipose afferent 
activators, none have described a single ligand or process capable of inhibiting this 
neuronal population. Inhibitory mechanisms of this circuit are critical to elucidate 
because of the seemingly feed-forward capability of this SNS-induced lipolysis sensing 
circuit that promotes SNS increases (Niijima, 1999). Finding the anatomical level and 
process of adipose afferent inhibition may be key to discovering how obesity—a state 
where adipose afferent activators are high (e.g. leptin, lipolysis)—and hypertension (i.e. 
an output of the adipose afferent reflex) are interrelated.   
Our unique chemogenetic approach to control WAT afferent activity, although 
largely inconclusive as to if these afferents affect in vivo metabolic processes, showed 
that AAV-induced translation of functional DREADDs on WAT afferents is possible. 
This positive result will guide future advancements into how we can discover the 
function of these and other adipose afferents. These principles cannot only be extended 
to measure functional effects of BAT afferents but also to test the necessity and 
sufficiency of afferents from other organs (e.g. muscle, gut, liver). In addition, specific 
control of adipose afferents could prove clinically beneficial given their dysregulation in 
obesity hypertension (Xiong et al., 2012). Stepwise and progressive experiments that 
test the potential capacities of WAT and BAT afferents will continue to deepen our 
understanding of the complex integration of adipose tissue physiology with energy 
balance.  
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